# EDGAR Filing Document

**Accession Number:** 0001096343
**File Stem:** 0001096343-26-000041
**Filing Date:** 2026-4
**Character Count:** 180339
**Document Hash:** d8c2cdbbfab35604baaa810bd0b112a3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001096343-26-000041.hdr.sgml**: 20260428

**ACCESSION NUMBER**: 0001096343-26-000041

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 64

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260428

**DATE AS OF CHANGE**: 20260428

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MARKEL GROUP INC.
- **CENTRAL INDEX KEY:** 0001096343
- **STANDARD INDUSTRIAL CLASSIFICATION:** FIRE, MARINE & CASUALTY INSURANCE [6331]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 541959284
- **STATE OF INCORPORATION:** VA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-15811
- **FILM NUMBER:** 26908410

**BUSINESS ADDRESS:**
- **STREET 1:** 4521 HIGHWOODS PARKWAY
- **CITY:** GLEN ALLEN
- **STATE:** VA
- **ZIP:** 23060-6148
- **BUSINESS PHONE:** 8047470136

**MAIL ADDRESS:**
- **STREET 1:** 4521 HIGHWOODS PKWY
- **CITY:** GLEN ALLEN
- **STATE:** VA
- **ZIP:** 23060

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MARKEL GROUP, INC.
- **DATE OF NAME CHANGE:** 20230526

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MARKEL CORP
- **DATE OF NAME CHANGE:** 20000411

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MARKEL HOLDINGS INC
- **DATE OF NAME CHANGE:** 19991005

?xml version='1.0' encoding='ASCII'? mkl-20260331

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**___________________________________________**

**FORM 10-Q**

**______________________________________________________________________________________**

☒**&nbsp;&nbsp;&nbsp;&nbsp;Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2026** 

**or**

☐**&nbsp;&nbsp;&nbsp;&nbsp;Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from _______ to _______**

**Commission File Number: 001-15811** 

**_________________________________________**

**MARKEL GROUP INC.** 

**(Exact name of registrant as specified in its charter)**

**___________________________________________________________________________________**

---

| | |
|:---|:---|
| **Virginia** | **54-1959284** |
| **(State or other jurisdiction of<br>incorporation or organization)** | **(I.R.S. Employer<br>Identification No.)** |

---

**4521 Highwoods Parkway, Glen Allen, Virginia 23060-6148** 

**(Address of principal executive offices) (Zip Code)**

**(804) 747-0136** 

**(Registrant**'**s telephone number, including area code)**

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of exchange on which registered** |
| **Common Stock, no par value** | **MKL** | **New York Stock Exchange** |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes ⌧ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes ⌧No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ⌧ Accelerated filer ☐ Non-accelerated filer ☐ <br> Smaller reporting company ☐ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;No ⌧

Number of shares of the registrant's common stock outstanding at April 21, 2026: 12,513,710

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**Markel Group Inc.**

**Form 10-Q**

**Index**

---

| | | |
|:---|:---|:---|
| | | **Page Number** |
| <u>[PART I. FINANCIAL INFORMATION](#i0d3a8af7c48740ac94a3c2b8c9b465ff_10)</u> | <u>[PART I. FINANCIAL INFORMATION](#i0d3a8af7c48740ac94a3c2b8c9b465ff_10)</u> |  |
| Item 1. | <u>[Financial Statements](#i0d3a8af7c48740ac94a3c2b8c9b465ff_13)</u> |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Balance Sheets—March 31, 2026 and December 31, 2025](#i0d3a8af7c48740ac94a3c2b8c9b465ff_16)</u> | [3](#i0d3a8af7c48740ac94a3c2b8c9b465ff_16) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Income (Loss) and Comprehensive Income (Loss)—Three Months Ended March 31, 2026 and 2025](#i0d3a8af7c48740ac94a3c2b8c9b465ff_19)</u> | [4](#i0d3a8af7c48740ac94a3c2b8c9b465ff_19) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Changes in Equity—Three Months Ended March 31, 2026 and 2025](#i0d3a8af7c48740ac94a3c2b8c9b465ff_22)</u> | [5](#i0d3a8af7c48740ac94a3c2b8c9b465ff_22) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Cash Flows—Three Months Ended March 31, 2026 and 2025](#i0d3a8af7c48740ac94a3c2b8c9b465ff_25)</u> | [6](#i0d3a8af7c48740ac94a3c2b8c9b465ff_25) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Notes to Consolidated Financial Statements](#i0d3a8af7c48740ac94a3c2b8c9b465ff_28)</u> | [7](#i0d3a8af7c48740ac94a3c2b8c9b465ff_28) |
| Item 2. | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i0d3a8af7c48740ac94a3c2b8c9b465ff_64)</u> | [22](#i0d3a8af7c48740ac94a3c2b8c9b465ff_64) |
| Item 3. | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i0d3a8af7c48740ac94a3c2b8c9b465ff_148)</u> | [39](#i0d3a8af7c48740ac94a3c2b8c9b465ff_148) |
| Item 4. | <u>[Controls and Procedures](#i0d3a8af7c48740ac94a3c2b8c9b465ff_151)</u> | [40](#i0d3a8af7c48740ac94a3c2b8c9b465ff_151) |
| <u>[PART II. OTHER INFORMATION](#i0d3a8af7c48740ac94a3c2b8c9b465ff_154)</u> | <u>[PART II. OTHER INFORMATION](#i0d3a8af7c48740ac94a3c2b8c9b465ff_154)</u> |  |
| Item 1A. | <u>[Risk Factors](#i0d3a8af7c48740ac94a3c2b8c9b465ff_157)</u> | [40](#i0d3a8af7c48740ac94a3c2b8c9b465ff_157) |
| Item 2. | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i0d3a8af7c48740ac94a3c2b8c9b465ff_160)</u> | [41](#i0d3a8af7c48740ac94a3c2b8c9b465ff_160) |
| Item 5. | <u>[Other Information](#i0d3a8af7c48740ac94a3c2b8c9b465ff_163)</u> | [41](#i0d3a8af7c48740ac94a3c2b8c9b465ff_163) |
| Item 6. | <u>[Exhibits](#i0d3a8af7c48740ac94a3c2b8c9b465ff_166)</u> | [41](#i0d3a8af7c48740ac94a3c2b8c9b465ff_166) |
| <u>[Signatures](#i0d3a8af7c48740ac94a3c2b8c9b465ff_169)</u> | <u>[Signatures](#i0d3a8af7c48740ac94a3c2b8c9b465ff_169)</u> | [43](#i0d3a8af7c48740ac94a3c2b8c9b465ff_169) |

---

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**PART I. FINANCIAL INFORMATION**

**Item 1. FINANCIAL STATEMENTS**

**MARKEL GROUP INC. AND SUBSIDIARIES**

**CONSOLIDATED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | December 31,<br>2025 |
| *(dollars in thousands)* | (unaudited) |  |
| **ASSETS** |  |  |
| Investments, at estimated fair value: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed maturity securities, available-for-sale (amortized cost of $18,207,316 in 2026 and $17,895,918 in 2025) | $**17943781** | $17797986 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity securities (cost of $4,125,927 in 2026 and $4,094,745 in 2025) | **12302672** | 13004312 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term investments, available-for-sale (estimated fair value approximates cost) | **2026147** | 2033662 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Investments | **32272600** | 32835960 |
| Cash and cash equivalents | **3680461** | 3964705 |
| Restricted cash and cash equivalents | **500817** | 638597 |
| Receivables | **3808338** | 3964598 |
| Reinsurance recoverables | **15195825** | 14616279 |
| Deferred policy acquisition costs | **857246** | 909516 |
| Prepaid reinsurance premiums | **3273077** | 3073999 |
| Goodwill | **2836492** | 2822091 |
| Intangible assets | **1498534** | 1543002 |
| Other assets | **4678967** | 4536303 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Assets** | $**68602357** | $68905050 |
| **LIABILITIES AND EQUITY** |  |  |
| Unpaid losses and loss adjustment expenses | $**31370536** | $30857453 |
| Unearned premiums | **7234917** | 7253079 |
| Payables to insurance and reinsurance companies | **1615785** | 1667871 |
| Senior long-term debt and other debt (estimated fair value of $3,836,000 in 2026 and $3,856,000 in 2025) | **4382845** | 4303811 |
| Other liabilities | **5348174** | 5720647 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Liabilities | **49952257** | 49802861 |
| Redeemable noncontrolling interests | **519752** | 506064 |
| Commitments and contingencies |  |  |
| Shareholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock | **3707179** | 3672381 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | **14662404** | 15034835 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | **(237601)** | (109460) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Shareholders' Equity | **18131982** | 18597756 |
| Noncontrolling interests | **(1634)** | (1631) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Equity | **18130348** | 18596125 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Liabilities and Equity** | $**68602357** | $68905050 |

---

See accompanying notes to consolidated financial statements.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**MARKEL GROUP INC. AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)**

(Unaudited)

---

| | | |
|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, |
| | **2026** | 2025 |
| *(dollars in thousands, except per share data)* |  |  |
| **OPERATING REVENUES** |  |  |
| Earned premiums | $**2048886** | $2089374 |
| Net investment income | **255890** | 237095 |
| Products revenues | **572421** | 561124 |
| Services and other revenues | **673408** | 660583 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Operating Revenues | **3550605** | 3548176 |
| Net investment losses | **(727562)** | (149071) |
| **OPERATING EXPENSES** |  |  |
| Losses and loss adjustment expenses | **1166817** | 1254665 |
| Underwriting, acquisition, and insurance expenses | **739828** | 747438 |
| Products expenses | **517430** | 499908 |
| Services and other expenses | **628784** | 567628 |
| Amortization of acquired intangible assets | **43513** | 46942 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Operating Expenses | **3096372** | 3116581 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating Income (Loss) | **(273329)** | 282524 |
| Interest expense | **(50886)** | (52140) |
| Net foreign exchange gains (losses) | **54277** | (72633) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income (Loss) Before Income Taxes | **(269938)** | 157751 |
| Income tax (expense) benefit | **65582** | (28404) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net Income (Loss)** | **(204356)** | 129347 |
| Net income attributable to noncontrolling interests | **(7933)** | (7633) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net Income (Loss) to Shareholders** | **(212289)** | 121714 |
| **OTHER COMPREHENSIVE INCOME (LOSS)** |  |  |
| Change in net unrealized losses on available-for-sale investments, net of taxes | **(133821)** | 218377 |
| Other, net of taxes | **5717** | 7552 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Other Comprehensive Income (Loss) | **(128104)** | 225929 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Comprehensive Income (Loss)** | **(332460)** | 355276 |
| Comprehensive income attributable to noncontrolling interests | **(7970)** | (7606) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Comprehensive Income (Loss) to Shareholders** | $**(340430)** | $347670 |
| **NET INCOME (LOSS) PER COMMON SHARE** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $**(18.90)** | $12.11 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $**(18.90)** | $12.08 |

---

See accompanying notes to consolidated financial statements.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**MARKEL GROUP INC. AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY**

(Unaudited)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Three Months Ended March 31, 2026** | Common<br>Stock | Retained<br>Earnings | Accumulated Other Comprehensive Loss | Total<br>Shareholders'<br>Equity | Noncontrolling<br>Interests | Total Equity | Redeemable<br>Noncontrolling<br>Interests |
| *(dollars in thousands)* |  |  |  |  |  |  |  |
| December 31, 2025 | $3672381 | $15034835 | $(109460) | $18597756 | $(1631) | $18596125 | $506064 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) |  | **(212289)** | **—** | **(212289)** | **—** | **(212289)** | **7933** |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) |  | **—** | **(128141)** | **(128141)** | **—** | **(128141)** | **37** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Comprehensive income (loss) |  |  |  | **(340430)** | **—** | **(340430)** | **7970** |
| &nbsp;&nbsp;&nbsp;&nbsp;Repurchase of common stock | **—** | **(133931)** | **—** | **(133931)** | **—** | **(133931)** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity awards expensed | **36943** | **—** | **—** | **36943** | **—** | **36943** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustment of redeemable noncontrolling interests | **—** | **(26437)** | **—** | **(26437)** | **—** | **(26437)** | **26437** |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchase of noncontrolling interests | **—** | **—** | **—** | **—** | **—** | **—** | **(9495)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | **(2145)** | **226** | **—** | **(1919)** | **(3)** | **(1922)** | **(11224)** |
| March 31, 2026 | $**3707179** | $**14662404** | $**(237601)** | $**18131982** | $**(1634)** | $**18130348** | $**519752** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Three Months Ended March 31, 2025** | Preferred<br> Stock | Common<br>Stock | Retained<br>Earnings | Accumulated Other Comprehensive Loss | Total<br>Shareholders'<br>Equity | Noncontrolling<br>Interests | Total Equity | Redeemable<br>Noncontrolling<br>Interests |
| *(dollars in thousands)* |  |  |  |  |  |  |  |  |
| December 31, 2024 | $591891 | $3560633 | $13380456 | $(617082) | $16915898 | $13041 | $16928939 | $540034 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income |  |  | 121714 |  | 121714 | 3192 | 124906 | 4441 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) |  |  |  | 225956 | 225956 |  | 225956 | (27) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Comprehensive income |  |  |  |  | 347670 | 3192 | 350862 | 4414 |
| &nbsp;&nbsp;&nbsp;&nbsp;Repurchase of common stock |  |  | (170270) |  | (170270) |  | (170270) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity awards expensed |  | 22307 |  |  | 22307 |  | 22307 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition of EPI |  |  |  |  |  |  |  | 81201 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustment of redeemable noncontrolling interests |  |  | 33341 |  | 33341 |  | 33341 | (33341) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other |  | (8) | (431) |  | (439) | 2 | (437) | (12569) |
| March 31, 2025 | $591891 | $3582932 | $13364810 | $(391126) | $17148507 | $16235 | $17164742 | $579739 |

---

See accompanying notes to consolidated financial statements.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**MARKEL GROUP INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

(Unaudited)

---

| | | |
|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, |
| | **2026** | 2025 |
| *(dollars in thousands)* |  |  |
| **OPERATING ACTIVITIES** |  |  |
| Net income (loss) | $**(204356)** | $129347 |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities | **220268** | 246845 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net Cash Provided By Operating Activities | **15912** | 376192 |
| **INVESTING ACTIVITIES** |  |  |
| Proceeds from sales, maturities, calls, and prepayments of fixed maturity securities | **547820** | 500466 |
| Cost of fixed maturity securities purchased | **(819452)** | (742665) |
| Proceeds from sales of equity securities | **52107** | 31795 |
| Cost of equity securities purchased | **(80072)** | (88531) |
| Net change in short-term investments | **19595** | 447436 |
| Additions to property and equipment | **(47265)** | (40713) |
| Acquisitions, net of cash acquired | **(20160)** |  |
| Other | **(791)** | 85017 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net Cash Provided (Used) By Investing Activities | **(348218)** | 192805 |
| **FINANCING ACTIVITIES** |  |  |
| Additions to senior long-term debt and other debt | **295472** | 263456 |
| Repayment of senior long-term debt and other debt | **(217063)** | (202809) |
| Repurchases of common stock | **(133931)** | (170270) |
| Other | **(24027)** | 3828 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net Cash Used By Financing Activities | **(79549)** | (105795) |
| Effect of foreign currency rate changes on cash, cash equivalents, restricted cash, and restricted cash equivalents | **(10169)** | 19492 |
| Increase (decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents | **(422024)** | 482694 |
| Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period | **4603302** | 4192248 |
| **CASH, CASH EQUIVALENTS, RESTRICTED CASH, AND RESTRICTED CASH EQUIVALENTS AT END OF PERIOD** | $**4181278** | $4674942 |

---

See accompanying notes to consolidated financial statements.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**MARKEL GROUP INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**1. Summary of Significant Accounting Policies** 

Markel Group Inc. (Markel Group) is a holding company comprised of a diverse group of businesses and investments with specialty insurance at its core. See note 2 for details regarding reportable segments.

**a) Basis of Presentation.** The consolidated balance sheet as of March 31, 2026 and the related consolidated statements of income (loss) and comprehensive income (loss) and changes in equity for the three months ended March 31, 2026 and 2025 and the condensed consolidated statements of cash flows for the three months ended March 31, 2026 and 2025 are unaudited. In the opinion of management, all adjustments necessary for fair presentation of such consolidated financial statements have been included. Such adjustments consist only of normal, recurring items. Interim results are not necessarily indicative of results of operations for the entire year. The consolidated balance sheet as of December 31, 2025 was derived from Markel Group's audited annual consolidated financial statements.

The accompanying consolidated financial statements have been prepared in accordance with United States (U.S.) generally accepted accounting principles (GAAP) and include the accounts of Markel Group and its consolidated subsidiaries, as well as variable interest entities that meet the requirements for consolidation (the Company). All significant intercompany balances and transactions have been eliminated in consolidation. The Company consolidates the results of its non-insurance operating businesses on a one-month lag, with the exception of significant transactions or events that occur during the intervening period. Certain prior period amounts have been reclassified to conform to the current period presentation.

The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses, and the disclosure of contingent assets and liabilities. Actual results may differ materially from the estimates and assumptions used in preparing the consolidated financial statements.

The consolidated financial statements and notes are presented as permitted by Form 10-Q and do not contain certain information included in the Company's annual consolidated financial statements and notes. For a more complete description of the Company's business and accounting policies, readers are urged to review the Company's 2025 Annual Report on Form 10-K.

**b) Recent Accounting Pronouncements**

In November 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2024-03, *Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures.* The standard requires disclosure of certain prescribed costs and expenses within the notes to consolidated financial statements. ASU No. 2024-03 becomes effective for the Company's 2027 Annual Report on Form 10-K. The standard only impacts required disclosures and will not impact the Company's financial position, results of operations, or cash flows. The Company is currently in the early stages of evaluating the impact of ASU No. 2024-03 on its disclosures.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**2. Segment Reporting Disclosures** 

The Company has four reportable segments: Markel Insurance, Industrial, Financial, and Consumer and Other.

The Markel Insurance segment is the Company's core specialty insurance business, which is comprised of underwriting and other insurance-related activities. The Markel Insurance segment aligns with the business's network of insurance subsidiaries under the common leadership of the Markel Insurance chief executive officer. In August 2025, Markel Insurance sold the renewal rights for business written in its Global Reinsurance division, and the division entered into run-off. The Global Reinsurance division's gross premium volume in 2025 was $1.0 billion. As many of the contracts previously written within this division are multi-year agreements, the Company expects premiums to continue earning over the next two years and loss reserves are expected to take several additional years to run off.

The Industrial segment consists of businesses that operate in the industrial sector. These businesses distribute building products, provide fire protection and life safety solutions, and manufacture a variety of products, including precast concrete, car hauler equipment, industrial baking equipment, flooring for dry van trailers, dredges, and wall systems. Other businesses in the Industrial segment provide equipment rental services and erosion control and stormwater management services.

The Financial segment consists of businesses that operate in the insurance services and investment management industries, as well as certain insurance-linked securities investment management businesses that are in run-off.

The Consumer and Other segment consists of businesses that operate in the consumer sector, as well as a variety of other sectors, including information technology, real estate, and healthcare. These businesses produce ornamental houseplants, build homes, design leather handbags, and own and operate manufactured housing communities. Other businesses in the Consumer and Other segment provide information technology consulting services, retail intelligence, concierge primary healthcare, and sponsorship of international teachers.

The Company's corporate operations, which are not an operating or reportable segment, are comprised of holding company activities, which include capital allocation, leadership support, and performing the responsibilities consistent with sound governance and required of a public company. The Company's corporate operations include activities at Markel Group Inc. and investments and loans to and from its operating businesses, which are held by other corporate subsidiaries. Historically, corporate expenses were fully allocated to the Company's segment results, however, beginning in the third quarter of 2025, the Company discontinued allocating corporate expenses that are not integral to operating its underlying businesses.

Intersegment transactions primarily consist of loans from Markel Insurance to a corporate subsidiary to fund certain non-insurance acquisitions and from a corporate subsidiary to certain non-insurance businesses to fund strategic growth investments and projects. The Company's chief operating decision maker considers these loans, and the related interest income, to be similar to invested assets held by the respective segment. Interest income on these intercompany loans is included in the respective segment's profit and is eliminated in consolidation.

Segment profit for all of the Company's segments is measured by adjusted operating income, which does not include net investment gains, amortization of acquired intangible assets, or impairment of goodwill. Net investment gains and losses, which are primarily comprised of unrealized gains and losses on equity securities, are evaluated separately by the chief operating decision maker when assessing periodic segment financial performance due to the inherent volatility of these gains and losses, which can temporarily obscure the underlying segment performance. The chief operating decision maker believes such amounts are more meaningful when evaluated over longer periods of time. Amortization of acquired intangible assets and impairment of goodwill, which arise from purchase accounting for acquisitions, are not considered a cost of operating the underlying businesses.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**a)** The following tables summarize the Company's segment disclosures. The Company's chief operating decision maker reviews net investment gains and losses by segment separately from the Company's segment profit.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 |
| *<u>(dollars in thousands)</u>* | Markel Insurance | Industrial | Financial | Consumer and Other | Corporate and eliminations | Consolidated |
| Earned premiums | $**1969339** | $**—** | $**79547** | $**—** | $**—** | $**2048886** |
| Net investment income | **229619** | **—** | **9130** | **—** | **17141** | **255890** |
| Products revenues | **—** | **397725** | **—** | **174696** | **—** | **572421** |
| Services and other revenues | **2727** | **485333** | **72853** | **105801** | **6694** | **673408** |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating revenues | **2201685** | **883058** | **161530** | **280497** | **23835** | **3550605** |
| Losses and loss adjustment expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current accident year - attritional | **(1185910)** | **—** | **(49942)** | **—** | **—** | **(1235852)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Current accident year - catastrophe <sup>(1)</sup> | **(35028)** | **—** | **—** | **—** | **—** | **(35028)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Prior accident years | **106939** | **—** | **(2876)** | **—** | **—** | **104063** |
| Underwriting, acquisition, and insurance expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of policy acquisition costs | **(406729)** | **—** | **(6201)** | **—** | **—** | **(412930)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Other underwriting expenses | **(306362)** | **—** | **(20536)** | **—** | **—** | **(326898)** |
| Products expenses | **—** | **(359950)** | **—** | **(157480)** | **—** | **(517430)** |
| Services and other expenses | **(5105)** | **(473822)** | **(45770)** | **(83262)** | **(20825)** | **(628784)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating income | $**369490** | $**49286** | $**36205** | $**39755** | $**3010** | $**497746** |
| Net investment losses |  |  |  |  |  | **(727562)** |
| Amortization of acquired intangible assets |  |  |  |  |  | **(43513)** |
| Interest expense |  |  |  |  |  | **(50886)** |
| Net foreign exchange gains |  |  |  |  |  | **54277** |
| Loss before income taxes |  |  |  |  |  | $**(269938)** |

---

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Catastrophe current accident year losses and loss adjustment expenses were attributable to the Middle East conflict.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 |
| *<u>(dollars in thousands)</u>* | Markel Insurance | Industrial | Financial | Consumer and Other | Corporate | Consolidated |
| Net investment gains (losses) | $**(553914)** | $**—** | $**369** | $**—** | $**(174017)** | $**(727562)** |

---

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 |
| *<u>(dollars in thousands)</u>* | Markel Insurance | Industrial | Financial | Consumer and Other | Corporate and eliminations | Consolidated |
| Earned premiums | $2016539 | $— | $72835 | $— | $— | $2089374 |
| Net investment income | 207517 |  | 8952 |  | 20626 | 237095 |
| Products revenues |  | 369245 |  | 191879 |  | 561124 |
| Services and other revenues | 2620 | 460329 | 96694 | 95907 | 5033 | 660583 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating revenues | 2226676 | 829574 | 178481 | 287786 | 25659 | 3548176 |
| Losses and loss adjustment expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current accident year - attritional | (1295523) |  | (43185) |  |  | (1338708) |
| &nbsp;&nbsp;&nbsp;&nbsp;Current accident year - catastrophe | (66064) |  |  |  |  | (66064) |
| &nbsp;&nbsp;&nbsp;&nbsp;Prior accident years | 148837 |  | 1270 |  |  | 150107 |
| Underwriting, acquisition, and insurance expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of policy acquisition costs | (411276) |  | (5746) |  |  | (417022) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other underwriting expenses | (312351) |  | (18065) |  |  | (330416) |
| Products expenses |  | (326035) |  | (173873) |  | (499908) |
| Services and other expenses | (8184) | (444775) | (33144) | (81525) |  | (567628) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating income | $282115 | $58764 | $79611 | $32388 | $25659 | $478537 |
| Net investment losses |  |  |  |  |  | (149071) |
| Amortization of acquired intangible assets |  |  |  |  |  | (46942) |
| Interest expense |  |  |  |  |  | (52140) |
| Net foreign exchange losses |  |  |  |  |  | (72633) |
| Income before income taxes |  |  |  |  |  | $157751 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 |
| *<u>(dollars in thousands)</u>* | Markel Insurance | Industrial | Financial | Consumer and Other | Corporate | Consolidated |
| Net investment gains (losses) | $(224194) | $— | $— | $— | $75123 | $(149071) |

---

**b)** The chief operating decision maker also reviews capital expenditures attributable to the Industrial and Consumer and Other segments.

---

| | | |
|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, |
| *<u>(dollars in thousands)</u>* | **2026** | 2025 |
| Industrial | $**22636** | $16434 |
| Consumer and Other | $**11268** | $11521 |

---

**c)** The following table reconciles segment assets to the Company's consolidated balance sheets.

---

| | | |
|:---|:---|:---|
| *<u>(dollars in thousands)</u>* | **March 31, 2026** | December 31, 2025 |
| Segment assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Markel Insurance | $**43473248** | $44314601 |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrial | **3989709** | 3965449 |
| &nbsp;&nbsp;&nbsp;&nbsp;Financial | **15057582** | 14444426 |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer and Other | **1813388** | 1783183 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total segment assets | **64333927** | 64507659 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate and eliminations | **4268430** | 4397391 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $**68602357** | $68905050 |

---

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**3. Investments** 

**a)** The following tables summarize the Company's available-for-sale investments. Agency mortgage-backed securities include securities issued by U.S. government-sponsored enterprises and U.S. government agencies. The net unrealized holding gains (losses) in the tables below are presented before taxes.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | March 31, 2026 | March 31, 2026 | March 31, 2026 | March 31, 2026 |
| *<u>(dollars in thousands)</u>* | Amortized<br>Cost | Gross<br>Unrealized<br>Holding<br>Gains | Gross<br>Unrealized<br>Holding<br>Losses | Estimated<br>Fair<br>Value |
| Fixed maturity securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Treasury securities | $**5992327** | $**33328** | $**(23853)** | $**6001802** |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. government-sponsored enterprises | **1715840** | **13140** | **(64358)** | **1664622** |
| &nbsp;&nbsp;&nbsp;&nbsp;Obligations of states, municipalities, and political subdivisions | **3759474** | **24502** | **(111523)** | **3672453** |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign governments, agencies, and supranationals | **3484109** | **51406** | **(111258)** | **3424257** |
| &nbsp;&nbsp;&nbsp;&nbsp;Agency mortgage-backed securities | **2978312** | **15434** | **(66982)** | **2926764** |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-agency mortgage-backed securities | **54756** | **—** | **(701)** | **54055** |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate and university bonds | **222498** | **189** | **(22859)** | **199828** |
| &nbsp;&nbsp;&nbsp;&nbsp;Total fixed maturity securities | **18207316** | **137999** | **(401534)** | **17943781** |
| Short-term investments | **2027082** | **1526** | **(2461)** | **2026147** |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments, available-for-sale | $**20234398** | $**139525** | $**(403995)** | $**19969928** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | December 31, 2025 | December 31, 2025 | December 31, 2025 | December 31, 2025 |
| *<u>(dollars in thousands)</u>* | Amortized<br>Cost | Gross<br>Unrealized<br>Holding<br>Gains | Gross<br>Unrealized<br>Holding<br>Losses | Estimated<br>Fair<br>Value |
| Fixed maturity securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Treasury securities | $5877779 | $63769 | $(13641) | $5927907 |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. government-sponsored enterprises | 1678599 | 19378 | (57743) | 1640234 |
| &nbsp;&nbsp;&nbsp;&nbsp;Obligations of states, municipalities, and political subdivisions | 3743154 | 34871 | (105557) | 3672468 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign governments, agencies, and supranationals | 3359014 | 89595 | (73694) | 3374915 |
| &nbsp;&nbsp;&nbsp;&nbsp;Agency mortgage-backed securities | 2935758 | 24903 | (59541) | 2901120 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-agency mortgage-backed securities | 66296 |  | (538) | 65758 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate and university bonds | 235318 | 368 | (20102) | 215584 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total fixed maturity securities | 17895918 | 232884 | (330816) | 17797986 |
| Short-term investments | 2029650 | 4632 | (620) | 2033662 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments, available-for-sale | $19925568 | $237516 | $(331436) | $19831648 |

---

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**b)** The following tables summarize gross unrealized investment losses on available-for-sale investments by the length of time that securities have continuously been in an unrealized loss position.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | March 31, 2026 | March 31, 2026 | March 31, 2026 | March 31, 2026 | March 31, 2026 | March 31, 2026 |
| | Less than 12 months | Less than 12 months | 12 months or longer | 12 months or longer | Total | Total |
| *<u>(dollars in thousands)</u>* | Estimated<br>Fair<br>Value | Gross<br>Unrealized<br>Holding Losses | Estimated<br>Fair<br>Value | Gross<br>Unrealized<br>Holding Losses | Estimated<br>Fair<br>Value | Gross<br>Unrealized<br>Holding<br>Losses |
| Fixed maturity securities: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Treasury securities | $**1109592** | $**(5438)** | $**1165863** | $**(18415)** | $**2275455** | $**(23853)** |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. government-sponsored enterprises | **181210** | **(1027)** | **766475** | **(63331)** | **947685** | **(64358)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Obligations of states, municipalities, and political subdivisions | **511759** | **(3887)** | **1762168** | **(107636)** | **2273927** | **(111523)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign governments, agencies, and supranationals | **798190** | **(17276)** | **1131345** | **(93982)** | **1929535** | **(111258)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Agency mortgage-backed securities | **529219** | **(5626)** | **1359971** | **(61356)** | **1889190** | **(66982)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-agency mortgage-backed securities | **5857** | **(42)** | **48198** | **(659)** | **54055** | **(701)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate and university bonds | **21097** | **(535)** | **176540** | **(22324)** | **197637** | **(22859)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Total fixed maturity securities | **3156924** | **(33831)** | **6410560** | **(367703)** | **9567484** | **(401534)** |
| Short-term investments | **1189488** | **(2461)** | **—** | **—** | **1189488** | **(2461)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $**4346412** | $**(36292)** | $**6410560** | $**(367703)** | $**10756972** | $**(403995)** |

---

At March 31, 2026, the Company held 1,102 available-for-sale securities in an unrealized loss position with a total estimated fair value of $10.8 billion and gross unrealized losses of $404.0 million. Of these 1,102 securities, 808 securities had been in a continuous unrealized loss position for one year or longer and had a total estimated fair value of $6.4 billion and gross unrealized losses of $367.7 million.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | December 31, 2025 | December 31, 2025 | December 31, 2025 | December 31, 2025 | December 31, 2025 | December 31, 2025 |
| | Less than 12 months | Less than 12 months | 12 months or longer | 12 months or longer | Total | Total |
| *<u>(dollars in thousands)</u>* | Estimated<br>Fair<br>Value | Gross<br>Unrealized<br>Holding <br>Losses | Estimated<br>Fair<br>Value | Gross<br>Unrealized<br>Holding <br>Losses | Estimated<br>Fair<br>Value | Gross<br>Unrealized<br>Holding <br>Losses |
| Fixed maturity securities: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Treasury securities | $197135 | $(470) | $1275453 | $(13171) | $1472588 | $(13641) |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. government-sponsored enterprises | 108490 | (112) | 802349 | (57631) | 910839 | (57743) |
| &nbsp;&nbsp;&nbsp;&nbsp;Obligations of states, municipalities, and political subdivisions | 184124 | (970) | 1871154 | (104587) | 2055278 | (105557) |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign governments, agencies, and supranationals | 214787 | (1008) | 1181298 | (72686) | 1396085 | (73694) |
| &nbsp;&nbsp;&nbsp;&nbsp;Agency mortgage-backed securities | 156553 | (701) | 1446048 | (58840) | 1602601 | (59541) |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-agency mortgage-backed securities | 5889 | (6) | 59869 | (532) | 65758 | (538) |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate and university bonds | 20488 | (174) | 180290 | (19928) | 200778 | (20102) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total fixed maturity securities | 887466 | (3441) | 6816461 | (327375) | 7703927 | (330816) |
| Short-term investments | 59179 | (620) |  |  | 59179 | (620) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $946645 | $(4061) | $6816461 | $(327375) | $7763106 | $(331436) |

---

At December 31, 2025, the Company held 948 available-for-sale securities in an unrealized loss position with a total estimated fair value of $7.8 billion and gross unrealized losses of $331.4 million. Of these 948 securities, 851 securities had been in a continuous unrealized loss position for one year or longer and had a total estimated fair value of $6.8 billion and gross unrealized losses of $327.4 million.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

The Company completes a detailed analysis each quarter to assess whether the decline in the fair value of any investment below its cost basis is the result of a credit loss. All available-for-sale securities with unrealized losses are reviewed. The Company considers many factors in completing its quarterly review of securities with unrealized losses for credit-related impairment to determine whether a credit loss exists, including the extent to which fair value is below cost, the implied yield to maturity, rating downgrades of the security, and whether or not the issuer has failed to make scheduled principal or interest payments. The Company also takes into consideration information about the financial condition of the issuer and industry factors that could negatively impact the issuer.

If the decline in fair value of an available-for-sale security below its amortized cost is considered to be the result of a credit loss, the Company compares the estimated present value of the cash flows expected to be collected to the amortized cost of the security. The extent to which the estimated present value of the cash flows expected to be collected is less than the amortized cost of the security represents the credit loss, which is recorded as an allowance and recognized in net income. The allowance is limited to the difference between the fair value and the amortized cost of the security. Any remaining decline in fair value represents the non-credit portion of the impairment, which is recognized in other comprehensive income. The Company did not have an allowance for credit losses for any available-for-sale securities as of March 31, 2026 or December 31, 2025. As of March 31, 2026 and December 31, 2025, gross unrealized losses on available-for-sale securities were the result of declines in the fair value of the investments due to increases in interest rates, which are expected to reverse as the securities mature, and foreign currency movements related to available-for-sale securities denominated in a foreign currency.

Quarterly, the Company also considers whether it intends to sell an available-for-sale security or if it is more likely than not that it will be required to sell a security before recovery of its amortized cost. In these instances, a decline in fair value is recognized in net income based on the fair value of the security at the time of assessment, resulting in a new cost basis for the security.

**c)** The amortized cost and estimated fair value of fixed maturity securities at March 31, 2026 are shown below by contractual maturity.

---

| | | |
|:---|:---|:---|
| *<u>(dollars in thousands)</u>* | Amortized<br>Cost | Estimated<br>Fair Value |
| Due in one year or less | $**2172638** | $**2171438** |
| Due after one year through five years | **6579483** | **6530862** |
| Due after five years through ten years | **5237767** | **5169709** |
| Due after ten years | **1184360** | **1090953** |
|  | **15174248** | **14962962** |
| Mortgage-backed securities | **3033068** | **2980819** |
| &nbsp;&nbsp;&nbsp;&nbsp;Total fixed maturity securities | $**18207316** | $**17943781** |

---

**d)** The following table presents the components of net investment income.

---

| | | |
|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, |
| *<u>(dollars in thousands)</u>* | **2026** | 2025 |
| Interest: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed maturity securities | $**164324** | $143345 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term investments | **17104** | 19673 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents and restricted cash and cash equivalents | **30956** | 39774 |
| Dividends on equity securities | **49336** | 40195 |
|  | **261720** | 242987 |
| Investment expenses | **(5830)** | (5892) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income | $**255890** | $237095 |

---

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**e)** The following table presents the components of net investment losses included in net income (loss) and the change in net unrealized losses included in other comprehensive income (loss). Gross realized investment gains and losses on fixed maturity securities, short-term investments, and other investments were not material to the consolidated financial statements and are presented on a net basis in the following table.

---

| | | |
|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, |
| *<u>(dollars in thousands)</u>* | **2026** | 2025 |
| Fixed maturity securities and short-term investments: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized investment gains (losses) | $**2043** | $(1801) |
| Equity securities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of securities sold during the period | **(1620)** | (1322) |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of securities held at the end of the period | **(727985)** | (145948) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total change in fair value | **(729605)** | (147270) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net investment losses | $**(727562)** | $(149071) |
| Change in net unrealized losses on available-for-sale investments included in other comprehensive income (loss): |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed maturity securities | $**(165604)** | $273213 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term investments | **(4947)** | 4014 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) | $**(170551)** | $277227 |

---

**4. Fair Value Measurements** 

FASB Accounting Standards Codification (ASC) 820, *Fair Value Measurements and Disclosures,* establishes a three-level hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure the assets or liabilities fall within different levels of the hierarchy, the classification is based on the lowest level input that is significant to the fair value measurement of the asset or liability.

Classification of assets and liabilities within the hierarchy considers the markets in which the assets and liabilities are traded and the reliability and transparency of the assumptions used to determine fair value. The hierarchy requires the use of observable market data when available. The levels of the hierarchy are defined as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1 – Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities traded in active markets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2 – Inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, and market-corroborated inputs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3 – Inputs to the valuation methodology are unobservable for the asset or liability and are significant to the fair value measurement.

In accordance with ASC 820, the Company determines fair value based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining fair value, the Company uses various methods, including the market, income, and cost approaches. The Company uses valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. The following section describes the valuation methodologies used by the Company to measure assets and liabilities at fair value, including an indication of the level within the fair value hierarchy in which each asset or liability is generally classified.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

*Available-for-sale investments and equity securities.* Available-for-sale investments and equity securities are recorded at fair value on a recurring basis. Available-for-sale investments include fixed maturity securities and short-term investments. Fair value is determined by the Company after considering various sources of information, including information provided by a third-party pricing service. The pricing service provides prices for substantially all of the Company's fixed maturity securities and equity securities. In determining fair value, the Company generally does not adjust the prices obtained from the pricing service. The Company obtains an understanding of the pricing service's valuation methodologies and related inputs, which include, but are not limited to, reported trades, benchmark yields, issuer spreads, bids, offers, duration, credit ratings, estimated cash flows, and prepayment speeds. The Company validates prices provided by the pricing service by reviewing prices from other pricing sources and analyzing pricing data in certain instances.

The Company has evaluated the various types of securities in its investment portfolio to determine an appropriate fair value hierarchy level based upon trading activity and the observability of market inputs. Level 1 investments include those traded on an active exchange, such as the New York Stock Exchange. Level 2 investments include U.S. Treasury securities, U.S. government-sponsored enterprises, municipal bonds, foreign government, agency, and supranational bonds, mortgage-backed securities, and corporate and university debt securities.

Fair value for available-for-sale investments and equity securities is measured based upon quoted prices in active markets, if available. Due to variations in trading volumes and the lack of quoted market prices, fixed maturity securities are classified as Level 2 investments. The fair value of fixed maturity securities is normally derived through recent reported trades for identical or similar securities, making adjustments through the reporting date based upon available market observable data previously described. If there are no recent reported trades, the fair value of fixed maturity securities may be derived through the use of matrix pricing or model processes, where future cash flow expectations are developed based upon collateral performance and discounted at an estimated market rate. Significant inputs used to determine the fair value of obligations of states, municipalities and political subdivisions, corporate and university bonds, and obligations of foreign governments, agencies and supranationals include reported trades, benchmark yields, issuer spreads, bids, offers, credit information, and estimated cash flows. Significant inputs used to determine the fair value of mortgage-backed securities include the type of underlying assets, benchmark yields, prepayment speeds, collateral information, tranche type and volatility, estimated cash flows, credit information, default rates, recovery rates, issuer spreads, and the year of issue.

*Senior long-term debt and other debt.* Senior long-term debt and other debt is carried at amortized cost with the estimated fair value disclosed on the consolidated balance sheets. Senior long-term debt and other debt is classified as Level 2 within the fair value hierarchy due to variations in trading volumes and the lack of quoted market prices. Fair value is generally derived through recent reported trades, making adjustments through the reporting date, if necessary, based upon available market observable data including U.S. Treasury securities and implied credit spreads. Significant inputs used to determine the fair value of senior long-term debt and other debt include reported trades, benchmark yields, issuer spreads, bids, and offers.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

The following tables present the balances of assets measured at fair value on a recurring basis by level within the fair value hierarchy.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | March 31, 2026 | March 31, 2026 | March 31, 2026 | March 31, 2026 |
| *<u>(dollars in thousands)</u>* | Level 1 | Level 2 | Level 3 | Total |
| Assets: |  |  |  |  |
| Investments: |  |  |  |  |
| Fixed maturity securities, available-for-sale: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Treasury securities | $**—** | $**6001802** | $**—** | $**6001802** |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. government-sponsored enterprises | **—** | **1664622** | **—** | **1664622** |
| &nbsp;&nbsp;&nbsp;&nbsp;Obligations of states, municipalities, and political subdivisions | **—** | **3672453** | **—** | **3672453** |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign governments, agencies, and supranationals | **—** | **3424257** | **—** | **3424257** |
| &nbsp;&nbsp;&nbsp;&nbsp;Agency mortgage-backed securities | **—** | **2926764** | **—** | **2926764** |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-agency mortgage-backed securities | **—** | **54055** | **—** | **54055** |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate and university bonds | **—** | **199828** | **—** | **199828** |
| &nbsp;&nbsp;&nbsp;&nbsp;Total fixed maturity securities, available-for-sale | **—** | **17943781** | **—** | **17943781** |
| Equity securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Insurance, banks, and other financial institutions | **4884952** | **—** | **—** | **4884952** |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrial, consumer, and all other | **7417720** | **—** | **—** | **7417720** |
| &nbsp;&nbsp;&nbsp;&nbsp;Total equity securities | **12302672** | **—** | **—** | **12302672** |
| Short-term investments, available-for-sale | **1824361** | **201786** | **—** | **2026147** |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investments | $**14127033** | $**18145567** | $**—** | $**32272600** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | December 31, 2025 | December 31, 2025 | December 31, 2025 | December 31, 2025 |
| *<u>(dollars in thousands)</u>* | Level 1 | Level 2 | Level 3 | Total |
| Assets: |  |  |  |  |
| Investments: |  |  |  |  |
| Fixed maturity securities, available-for-sale: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Treasury securities | $— | $5927907 | $— | $5927907 |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. government-sponsored enterprises |  | 1640234 |  | 1640234 |
| &nbsp;&nbsp;&nbsp;&nbsp;Obligations of states, municipalities, and political subdivisions |  | 3672468 |  | 3672468 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign governments, agencies, and supranationals |  | 3374915 |  | 3374915 |
| &nbsp;&nbsp;&nbsp;&nbsp;Agency mortgage-backed securities |  | 2901120 |  | 2901120 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-agency mortgage-backed securities |  | 65758 |  | 65758 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate and university bonds |  | 215584 |  | 215584 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total fixed maturity securities, available-for-sale |  | 17797986 |  | 17797986 |
| Equity securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Insurance, banks, and other financial institutions | 5441617 |  |  | 5441617 |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrial, consumer, and all other | 7562695 |  |  | 7562695 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total equity securities | 13004312 |  |  | 13004312 |
| Short-term investments, available-for-sale | 1843163 | 190499 |  | 2033662 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investments | $14847475 | $17988485 | $— | $32835960 |

---

The Company did not have any assets or liabilities measured at fair value on a non-recurring basis during the three months ended March 31, 2026 and 2025.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**5. Products, Services, and Other Revenues**

The following tables present revenues from contracts with customers by type, all of which are included in products revenues and services and other revenues in the consolidated statements of income (loss) and comprehensive income (loss), along with a reconciliation to the total of products revenues and services and other revenues.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 |
| *<u>(dollars in thousands)</u>* | Markel Insurance | Industrial | Financial | Consumer and Other | Corporate | Total |
| Products | $**—** | $**389488** | $**—** | $**174550** | $**—** | $**564038** |
| Services | **1542** | **457265** | **260** | **87358** | **—** | **546425** |
| Management fees | **—** | **—** | **41554** | **—** | **—** | **41554** |
| Total revenues from contracts with customers | **1542** | **846753** | **41814** | **261908** | **—** | **1152017** |
| Leasing revenues | **—** | **35020** | **—** | **17586** | **—** | **52606** |
| Fronting fees | **5451** | **—** | **43170** | **—** | **—** | **48621** |
| Equity method and other investments income (loss) | **(2279)** | **—** | **(12131)** | **—** | **6694** | **(7716)** |
| Other | **(1987)** | **1285** | **—** | **1003** | **—** | **301** |
| &nbsp;&nbsp;&nbsp;&nbsp;Total products, services, and other revenues | $**2727** | $**883058** | $**72853** | $**280497** | $**6694** | $**1245829** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 |
| *<u>(dollars in thousands)</u>* | Markel Insurance | Industrial | Financial | Consumer and Other | Corporate | Total |
| Products | $— | $362357 | $— | $191760 | $— | $554117 |
| Services | 1945 | 429894 | 470 | 78441 |  | 510750 |
| Management fees |  |  | 25868 |  |  | 25868 |
| Total revenues from contracts with customers | 1945 | 792251 | 26338 | 270201 |  | 1090735 |
| Leasing revenues |  | 36990 |  | 16658 |  | 53648 |
| Fronting fees | 3144 |  | 36510 |  |  | 39654 |
| Equity method and other investments income (loss) | (2516) | 46 | 33837 |  | 5033 | 36400 |
| Other | 47 | 287 | 9 | 927 |  | 1270 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total products, services, and other revenues | $2620 | $829574 | $96694 | $287786 | $5033 | $1221707 |

---

Receivables from contracts with customers, net of allowances for credit losses, were $642.7 million and $692.4 million as of March 31, 2026 and December 31, 2025, respectively.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**6. Unpaid Losses and Loss Adjustment Expenses** 

The following table presents a reconciliation of consolidated beginning and ending reserves for losses and loss adjustment expenses.

---

| | | |
|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, |
| *<u>(dollars in thousands)</u>* | **2026** | 2025 |
| Gross reserves for losses and loss adjustment expenses, beginning of year | $**30857453** | $26633094 |
| Reinsurance recoverables on unpaid losses, beginning of year | **14150484** | 11120367 |
| Net reserves for losses and loss adjustment expenses, beginning of year | **16706969** | 15512727 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of foreign currency rate changes on beginning of year balance | **(36345)** | 56701 |
| Adjusted net reserves for losses and loss adjustment expenses, beginning of year | **16670624** | 15569428 |
| Incurred losses and loss adjustment expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current accident year | **1270880** | 1404772 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prior accident years | **(104063)** | (150107) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total incurred losses and loss adjustment expenses | **1166817** | 1254665 |
| Payments: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current accident year | **35061** | 50284 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prior accident years | **1099676** | 901098 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total payments | **1134737** | 951382 |
| Effect of foreign currency rate changes on current year activity | **(582)** | 54 |
| Change in net reserves for losses and loss adjustment expenses of Markel CATCo Re | **—** | (121) |
| Retroactive reinsurance transaction with Hagerty Re | **(62202)** |  |
| Net reserves for losses and loss adjustment expenses, end of period | **16639920** | 15872644 |
| Reinsurance recoverables on unpaid losses, end of period | **14730616** | 12015613 |
| Gross reserves for losses and loss adjustment expenses, end of period | $**31370536** | $27888257 |

---

For the three months ended March 31, 2026, current accident year losses and loss adjustment expenses included $35.0 million of net losses and loss adjustment expenses attributed to the regional military conflict that emerged in the Middle East following U.S. and Israeli airstrikes on Iran on February 28, 2026. Net losses and loss adjustment expenses from the Middle East conflict were attributed to terrorism and marine war coverages written by the International division within the Markel Insurance segment. Loss estimates for incurred losses attributed to the Middle East conflict represent the Company's best estimate as of March 31, 2026 based upon information currently available. The Company's estimates for these losses are based on known losses and reported claims, as well as an analysis of the Company's ceded reinsurance contracts. Due to the inherent uncertainty associated with the assumptions surrounding the Middle East conflict, these estimates are subject to a wide range of variability.

While the Company believes the reserves for losses and loss adjustment expenses for the Middle East conflict as of March 31, 2026 are adequate based on information currently available, the Company continues to closely monitor reported claims, ceded reinsurance contract attachment, government actions, and areas impacted by the conflict and may adjust its loss estimates as new information becomes available. Additionally, as the Middle East conflict is ongoing, additional losses may be incurred in subsequent periods, and such losses may be material to the Company's results of operations, financial condition, and cash flows.

Effective January 1, 2026, the Company entered into a retroactive reinsurance agreement with Hagerty Reinsurance Limited (Hagerty Re) to reinsure its retained exposures on business written on behalf of Hagerty, Inc. (Hagerty) prior to January 1, 2026. Net losses and loss adjustment expenses on these ceded policies totaled $62.2 million as of December 31, 2025, for which the Company paid $54.1 million to Hagerty Re. See note 8 for additional details on the Company's transactions with Hagerty to transition the relationship to a fronting arrangement.

For the three months ended March 31, 2026, losses and loss adjustment expenses included $104.1 million of favorable development on prior years loss reserves, which included $64.4 million of net favorable development on the Company's professional liability, credit and surety, and workers' compensation insurance product lines within its Markel Insurance segment.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

For the three months ended March 31, 2025, current accident year losses and loss adjustment expenses included $66.1 million of net losses and loss adjustment expenses attributed to the series of wildfires that occurred in southern California in January 2025.

For the three months ended March 31, 2025, losses and loss adjustment expenses included $150.1 million of favorable development on prior years loss reserves, which included $125.2 million of net favorable development on the Company's professional liability, general liability, marine and energy, and workers' compensation insurance product lines within its Markel Insurance segment.

**7. Reinsurance** 

The following tables summarize the effect of reinsurance and retrocessional reinsurance on premiums written and earned. Fronting premiums are attributable to business written on behalf of third-party capacity providers, substantially all of which are ceded.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
| | **2026** | **2026** | **2026** | **2026** | 2025 | 2025 | 2025 | 2025 |
| *<u>(dollars in thousands)</u>* | Direct | Assumed | Ceded | Net Premiums | Direct | Assumed | Ceded | Net Premiums |
| Underwriting: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Written | $**2069454** | $**219774** | $**(444345)** | $**1844883** | $2135972 | $729042 | $(554725) | $2310289 |
| &nbsp;&nbsp;&nbsp;&nbsp;Earned | $**2222658** | $**340669** | $**(514558)** | $**2048769** | $2195483 | $438045 | $(544156) | $2089372 |
| Fronting: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Written | **927736** | **568058** | **(1495631)** | **163** | 773685 | 579531 | (1353214) | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Earned | **857540** | **367909** | **(1225332)** | **117** | 739245 | 244306 | (983549) | 2 |
| Consolidated: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Written | $**2997190** | $**787832** | $**(1939976)** | $**1845046** | $2909657 | $1308573 | $(1907939) | $2310291 |
| &nbsp;&nbsp;&nbsp;&nbsp;Earned | $**3080198** | $**708578** | $**(1739890)** | $**2048886** | $2934728 | $682351 | $(1527705) | $2089374 |

---

---

| | | |
|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, |
| | **2026** | 2025 |
| Ceded earned premiums to gross earned premiums | **46%** | 42% |
| Assumed earned premiums to net earned premiums | **35%** | 33% |

---

Substantially all of the incurred losses and loss adjustment expenses related to the Company's fronted premiums were ceded. These gross losses totaled $1.2 billion and $957.5 million for the three months ended March 31, 2026 and 2025, respectively.

The following table summarizes the effect of reinsurance and retrocessional reinsurance on losses and loss adjustment expenses in the Company's underwriting operations.

---

| | | |
|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, |
| *<u>(dollars in thousands)</u>* | **2026** | 2025 |
| Gross losses and loss adjustment expenses | $**1433996** | $1673509 |
| Ceded losses and loss adjustment expenses | **(267480)** | (418927) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net losses and loss adjustment expenses | $**1166516** | $1254582 |

---

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**8. Related Party Transactions**

The Company engages in certain related party transactions in the normal course of business at arm's length.

<u>Nephila</u>

*Fund Management*

The Company provides investment and insurance management services through Nephila Holdings Ltd. (together with its subsidiaries, Nephila). Nephila serves as the investment manager to several Bermuda based private funds (the Nephila Funds). To provide access for the Nephila Funds to a variety of insurance-linked securities in the property catastrophe, climate, and specialty insurance markets, Nephila also acts as an insurance manager to certain Bermuda licensed reinsurers and as the managing agent to Lloyd's Syndicates 2357, 2358, and 2359 (collectively, the Nephila Reinsurers). Neither the Nephila Funds nor the Nephila Reinsurers are consolidated by the Company. Nephila receives management fees for investment and insurance management services based on either the net asset value of the accounts managed or gross premium volume for the underlying risks to which the investors subscribed. For certain funds, Nephila may also receive performance fees based on their annual performance. For the three months ended March 31, 2026 and 2025, total fund management revenues attributed to unconsolidated entities managed by Nephila were $40.5 million and $25.5 million, respectively.

*Fronting*

The Company's fronting activities, which are provided through the Company's Markel Insurance operations and program services operations, include programs with the Nephila Reinsurers through which the Company writes insurance policies that are fully ceded to the Nephila Reinsurers in exchange for fronting fees. Through these programs, Nephila utilizes certain of the Company's licensed insurance companies to write a portion of its portfolio of U.S. catastrophe-exposed property and specialty risks. Gross premiums written through these programs that were ceded to the Nephila Reinsurers were $267.4 million and $389.3 million for the three months ended March 31, 2026 and 2025, respectively.

As of March 31, 2026 and December 31, 2025, reinsurance recoverables on the consolidated balance sheets included $267.6 million and $496.0 million, respectively, due from the Nephila Reinsurers. Under its programs with the Nephila Reinsurers, the Company bears underwriting risk for annual aggregate agreement year losses in excess of a limit the Company believes is unlikely to be exceeded. To the extent losses under these programs exceed the prescribed limits, the Company is obligated to pay such losses to the cedents without recourse to the Nephila Reinsurers. While the Company believes losses under these programs are unlikely, those losses, if incurred, could be material to the Company's consolidated results of operations and financial condition.

The Company has also entered into other assumed and ceded reinsurance transactions with the Nephila Reinsurers in the normal course of business, which are not material to the Company's consolidated financial statements.

<u>Hagerty</u>

The Company holds a minority ownership interest in Hagerty, which operates as a managing general agent focused on the global automobile enthusiast market and also includes Hagerty Re, a Bermuda Class 3 reinsurance company. The Company writes U.S. classic car business on behalf of Hagerty. Effective January 1, 2026, the Company's business with Hagerty transitioned to a fronting arrangement, whereby the Company receives a fronting fee in exchange for writing business on behalf of Hagerty and ceding it to Hagerty Re. Prior to transitioning to a fronting arrangement, the majority of the Company's business with Hagerty was ceded to Hagerty Re.

Gross written premiums attributable to Hagerty for the three months ended March 31, 2026 were $253.3 million, all of which were ceded, including $242.1 million ceded to Hagerty Re. For the three months ended March 31, 2025, gross written premiums attributable to Hagerty were $219.9 million, of which $169.7 million were ceded to Hagerty Re. In connection with the transition, the Company also entered into agreements with Hagerty Re to reinsure its retained exposures on business written on behalf of Hagerty prior to January 1, 2026. Net losses and loss adjustment expenses and unearned premiums on these ceded policies totaled $62.2 million and $92.5 million, respectively, as of December 31, 2025. See note 6 for additional details on the Company's retroactive reinsurance agreement with Hagerty.

As of March 31, 2026 and December 31, 2025, reinsurance recoverables on the consolidated balance sheets included $298.0 million and $317.1 million, respectively, due from Hagerty Re.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**9. Shareholders' Equity**

**a)** The Company has 50,000,000 shares of no par value common stock authorized. The following table presents a rollforward of changes in common shares issued and outstanding.

---

| | | |
|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, |
| *<u>(in ones)</u>* | **2026** | 2025 |
| Issued and outstanding common shares, beginning of period | **12589631** | 12790117 |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of common shares | **5371** | 2258 |
| &nbsp;&nbsp;&nbsp;&nbsp;Repurchase of common shares | **(64045)** | (89735) |
| Issued and outstanding common shares, end of period | **12530957** | 12702640 |

---

**b)** The Company has 10,000,000 shares of no par value preferred stock authorized, none of which were issued or outstanding at March 31, 2026 and December 31, 2025.

**c)** Net income (loss) per common share was determined by dividing adjusted net income (loss) to shareholders by the applicable weighted average common shares outstanding. Weighted average basic common shares outstanding include restricted stock units that are no longer subject to any contingencies for issuance, but for which corresponding shares have not been issued. Diluted net income (loss) per common share is computed by dividing adjusted net income (loss) to shareholders by the weighted average number of common shares and dilutive potential common shares outstanding during the period. The following table presents basic net income (loss) per common share and diluted net income (loss) per common share.

---

| | | |
|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, |
| *<u>(in thousands, except per share amounts)</u>* | **2026** | 2025 |
| Net income (loss) to shareholders | $**(212289)** | $121714 |
| Adjustment and purchase of redeemable noncontrolling interests | **(26437)** | 33341 |
| Adjusted net income (loss) to shareholders | $**(238726)** | $155055 |
| Weighted average basic common shares outstanding | **12630** | 12804 |
| Weighted average dilutive potential common shares from restricted stock units and restricted stock <sup>(1)</sup> | **—** | 33 |
| Weighted average diluted common shares outstanding | **12630** | 12837 |
| Basic net income (loss) per common share | $**(18.90)** | $12.11 |
| Diluted net income (loss) per common share <sup>(1)</sup> | $**(18.90)** | $12.08 |

---

<sup>(1)&nbsp;&nbsp;&nbsp;&nbsp;</sup>The impact of 39 thousand shares from restricted stock units and restricted stock awards was excluded from the computation of diluted earnings per common share for the three months ended March 31, 2026 because the effect would have been anti-dilutive.

**10. Contingencies** 

Contingencies arise in the normal course of the Company's operations and are not expected to have a material impact on the Company's financial condition or results of operations.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

The following discussion and analysis should be read in conjunction with the consolidated financial statements and related notes included under Item 1 Financial Statements and our 2025 Annual Report on Form 10-K. The accompanying consolidated financial statements and related notes have been prepared in accordance with United States (U.S.) generally accepted accounting principles (GAAP) and include the accounts of our holding company, Markel Group Inc. (Markel Group), and its consolidated subsidiaries, as well as any variable interest entities that meet the requirements for consolidation (the Company). This section is divided into the following sections:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Business Overview

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Results of Operations

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Financial Condition

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Non-GAAP Financial Measures

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Critical Accounting Estimates

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Safe Harbor and Cautionary Statement

**<u>Business Overview</u>**

Markel Group is a holding company that owns independently operated businesses across a range of industries. The cornerstone business, Markel Insurance, provides specialized insurance products that are not typically available through the standard insurance market. This insurance business sits at the center of the Company's strategy. It generates and holds capital used to support growth and investment across Markel Group. The other majority-owned businesses operate in diverse end markets, from industrial bakery equipment to ornamental plants to precast concrete. Markel Group also owns shares in publicly traded companies, which are primarily held within its insurance operations.

Markel Group supports each business by empowering leaders to make the best long-term decisions for their businesses. Customers, associates, and shareholders each benefit from this approach, given how it allows businesses to pursue opportunities that require time, stability, and trust. We believe this approach is difficult to replicate and makes Markel Group a distinctive home for businesses. The Company's long-term orientation and decision-making is rooted in the Company's culture, known as *The Markel Style,* which serves as a shared set of values that foster excellence and consistency across independent businesses, all while allowing each business to retain its entrepreneurial spirit.

A key principle of *The Markel Style* is building the value of the Company for shareholders. The design of Markel Group supports this goal by owning businesses that generate positive cash flows and redeploying those cash flows for additional growth. Markel Group has developed the skill and capability to redeploy capital efficiently, with low friction, across a large and diverse opportunity set, which includes reinvesting in existing businesses, acquiring majority-owned businesses, investing in publicly traded companies, and repurchasing Markel Group shares. Markel Group's unique company design and set of shared values have enabled it to compound shareholder capital at attractive rates over many decades.

Markel Group reports its business operations in four segments: Markel Insurance, Industrial, Financial, and Consumer and Other. See note 2 of the notes to consolidated financial statements for details regarding our reportable segments.

**<u>Results of Operations</u>**

The following table presents operating revenues by segment.

---

| | | |
|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, |
| *<u>(dollars in thousands)</u>* | **2026** | 2025 |
| Markel Insurance | $**2201685** | $2226676 |
| Industrial | **883058** | 829574 |
| Financial | **161530** | 178481 |
| Consumer and Other | **280497** | 287786 |
| Corporate and eliminations | **23835** | 25659 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating revenues | $**3550605** | $3548176 |

---

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

The following table presents consolidated operating income and a reconciliation to consolidated adjusted operating income, as well as adjusted operating income by segment. Consolidated adjusted operating income is a non-GAAP measure. See "Non-GAAP Financial Measures" for additional details.

---

| | | |
|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, |
| *<u>(dollars in thousands)</u>* | **2026** | 2025 |
| Operating income (loss) | $**(273329)** | $282524 |
| &nbsp;&nbsp;&nbsp;&nbsp;Add: Amortization of acquired intangible assets | **43513** | 46942 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Net investment losses | **(727562)** | (149071) |
| Adjusted operating income | $**497746** | $478537 |
| &nbsp;&nbsp;&nbsp;&nbsp;Markel Insurance | $**369490** | $282115 |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrial | **49286** | 58764 |
| &nbsp;&nbsp;&nbsp;&nbsp;Financial | **36205** | 79611 |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer and Other | **39755** | 32388 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate and eliminations | **3010** | 25659 |
| Adjusted operating income | $**497746** | $478537 |

---

Net investment gains and losses have caused, and are expected to continue to cause, significant volatility in our periodic operating income, net income, and comprehensive income. Net investment gains and losses are predominantly derived from our investments in publicly traded equity securities and typically include significant unrealized gains and losses from market value movements. We believe that net investment gains and losses, whether realized from sales or unrealized from market value movements, are distortive in understanding the short-term operating performance of our businesses. As such, we exclude net investment gains and losses from adjusted operating income. We believe adjusted operating income, both consolidated and by segment, is generally an accurate representation of the operating performance of our businesses in our periodic results.

The following table presents the components of comprehensive income (loss) to shareholders.

---

| | | |
|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, |
| *<u>(dollars in thousands)</u>* | **2026** | 2025 |
| Operating income (loss) | $**(273329)** | $282524 |
| Interest expense | **(50886)** | (52140) |
| Net foreign exchange gains (losses) | **54277** | (72633) |
| Income tax (expense) benefit | **65582** | (28404) |
| Net income attributable to noncontrolling interests | **(7933)** | (7633) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) to shareholders | **(212289)** | 121714 |
| Other comprehensive income (loss) to shareholders | **(128141)** | 225956 |
| &nbsp;&nbsp;&nbsp;&nbsp;Comprehensive income (loss) to shareholders | $**(340430)** | $347670 |

---

**Markel Insurance**

Markel Insurance is our core specialty insurance business comprised of empowered local leaders underwriting hard-to-place risks across the globe in service of their customers' needs. Markel Insurance generates income primarily through its core underwriting activities and by investing the capital held by its underwriting subsidiaries, as well as through other insurance-related activities, which includes fronting and strategic minority investments. Markel Insurance is primarily comprised of its U.S. Wholesale and Specialty, Program and Solutions, International, and Global Reinsurance divisions. Markel Insurance also includes the run-off of the discontinued intellectual property collateral protection insurance (IP CPI) product line, life and annuity reinsurance business, and certain asbestos and environmental exposures, none of which is managed through its divisions.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

We measure the operating performance of our Markel Insurance segment by its operating revenues and adjusted operating income, which represents operating income before net investment losses and amortization of acquired intangible assets. The following table summarizes the results of operations for our Markel Insurance segment.

---

| | | |
|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, |
| *<u>(dollars in thousands)</u>* | **2026** | 2025 |
| Earned premiums | $**1969339** | $2016539 |
| Net investment income | **229619** | 207517 |
| Services and other revenues | **2727** | 2620 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating revenues | $**2201685** | $2226676 |
| Losses and loss adjustment expenses | **(1113999)** | (1212750) |
| Underwriting, acquisition, and insurance expenses | **(713091)** | (723627) |
| Services and other expenses | **(5105)** | (8184) |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating income | $**369490** | $282115 |
| Combined ratio | **93%** | 96% |

---

The 31% increase in adjusted operating income for the three months ended March 31, 2026 was driven by higher underwriting profits and net investment income. For further details of Markel Insurance's investment performance, see "Consolidated Investment Results."

<u>Recent Developments</u>

*Middle East Conflict*

A regional military conflict emerged in the Middle East following U.S. and Israeli airstrikes on Iran on February 28, 2026. Underwriting results for the three months ended March 31, 2026 included $35.0 million, or two points on the combined ratio, of net losses and loss adjustment expenses attributed to the Middle East conflict. Our losses and loss adjustment expenses from the Middle East conflict were attributed to terrorism and marine war coverages written by the International division.

Loss estimates for incurred losses attributed to the Middle East conflict represent our best estimate as of March 31, 2026 based upon information currently available. Our estimates for these losses are based on known losses and reported claims, as well as an analysis of our ceded reinsurance contracts. Due to the inherent uncertainty associated with the assumptions surrounding the Middle East conflict, these estimates are subject to a wide range of variability. While we believe our reserves for losses and loss adjustment expenses for the Middle East conflict as of March 31, 2026 are adequate based on information currently available, we continue to closely monitor reported claims, ceded reinsurance contract attachment, government actions, and areas impacted by the conflict and may adjust our loss estimates as new information becomes available.

Additionally, as the Middle East conflict is ongoing, additional losses may be incurred in subsequent periods, and such losses may be material to our results of operations, financial condition, and cash flows. Covering these risk is core to our expertise as a global specialty insurer and we continue to underwrite risks in this region on a case by case basis. Furthermore, our marine war coverages allow for the re-rating of in-force premium on contracts at risk during the escalated risk environment. See Item 1A. Risk Factors for additional information on the risks and uncertainties associated with this event.

*Global Reinsurance*

In August 2025, Markel Insurance sold the renewal rights for business written in its Global Reinsurance division, and the division entered into run-off. Gross premium volume in 2025 attributed to the Global Reinsurance division was $1.0 billion, including $576.9 million for the three months ended March 31, 2025. As many of the contracts previously written within this division were multi-year agreements, we expect premiums to continue earning over the next two years and loss reserves to take several additional years to run off. Effective January 1, 2026, we reinsured the international marine and energy reinsurance business that was still on-risk, comprising $54.8 million of unearned premiums as of December 31, 2025.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

Gross premium volume in 2026 includes premiums attributed to contracts signed prior to the division being placed into run-off and changes in our estimate of ultimate premium volumes from in-force contracts. Additionally, gross premium volume in 2026 includes premiums on certain international reinsurance deals that are being fronted as part of the transition of the renewal rights. For the three months ended March 31, 2026, underwriting gross premium volume attributed to the Global Reinsurance division was $22.6 million and fronting gross premium volume was $77.0 million. The Global Reinsurance division combined ratio was 114% for the three months ended March 31, 2026, which had a two point unfavorable impact on the Markel Insurance segment combined ratio.

*Hagerty*

Effective January 1, 2026, Markel Insurance's business with Hagerty, Inc. (Hagerty) transitioned to a fronting arrangement, whereby Markel Insurance receives a fronting fee for writing business on behalf of Hagerty and ceding it to Hagerty Reinsurance Limited (Hagerty Re). Prior to transitioning to a fronting arrangement, the majority of our business with Hagerty was ceded to Hagerty Re.

For the three months ended March 31, 2026, fronting gross premium volume attributed to Hagerty was $253.3 million, all of which was ceded. For the three months ended March 31, 2025, underwriting gross premium volume attributed to Hagerty was $219.9 million, of which $169.7 million were ceded to Hagerty Re. In connection with the transition, we also entered into agreements with Hagerty Re to reinsure our retained exposures on business written on behalf of Hagerty prior to January 1, 2026. Net losses and loss adjustment expenses and unearned premiums on these ceded policies totaled $62.2 million and $92.5 million, respectively, as of December 31, 2025.

The following table summarizes the results of Markel Insurance's underwriting and other insurance-related activities.

---

| | | | |
|:---|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
| *<u>(dollars in thousands)</u>* | **2026** | 2025 | % Change |
| Gross premium volume | $**2802995** | $3171551 | (12)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Underwriting | $**2215573** | $2793406 | (21)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted underwriting <sup>(1)</sup> | $**2192993** | $1996551 | 10% |
| &nbsp;&nbsp;&nbsp;&nbsp;Fronting | $**587422** | $378145 | 55% |
| Net written premiums | $**1771228** | $2238676 | (21)% |
| Earned premiums | $**1969339** | $2016539 | (2)% |
| Underwriting profit | $**142249** | $80162 | 77% |
| Services and other income (loss) | $**2966** | $(3880) | NM <sup>(2)</sup> |
| **Underwriting Ratios** <sup>(3)</sup> |  |  | Point Change |
| Loss ratio |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current accident year loss ratio | **62.0%** | 67.5% | (5.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;Prior accident years loss ratio | **(5.4)%** | (7.4)% | 2.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss ratio | **56.6%** | 60.1% | (3.5) |
| Expense ratio | **36.2%** | 35.9% | 0.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Combined ratio | **92.8%** | 96.0% | (3.2) |
| Current accident year loss ratio catastrophe impact <sup>(4)</sup> | **1.8%** | 3.3% | (1.5) |
| Current accident year loss ratio, excluding catastrophe impact <sup>(1)</sup> | **60.2%** | 64.2% | (4.0) |
| Combined ratio, excluding current accident year catastrophe impact <sup>(1)</sup> | **91.0%** | 92.7% | (1.7) |

---

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;This metric is a non-GAAP financial measure. See "Non-GAAP Financial Measures" for additional details.

<sup>(2)</sup> &nbsp;&nbsp;&nbsp;&nbsp;NM - Not meaningful.

<sup>(3)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Amounts may not reconcile due to rounding.

<sup>(4)</sup> &nbsp;&nbsp;&nbsp;&nbsp;The point impact of catastrophes is calculated as the associated net losses and loss adjustment expenses divided by total earned premiums. For the three months ended March 31, 2026, catastrophe current accident year losses and loss adjustment expenses were attributable to the Middle East conflict.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

<u>Premiums</u>

The decrease in underwriting gross premium volume in our Markel Insurance segment for the three months ended March 31, 2026 was driven by the changes to our Global Reinsurance division and Hagerty relationship, as previously discussed. Adjusted underwriting gross premium volume, which excludes premiums attributed to the Global Reinsurance division and Hagerty in both periods, increased 10% driven by growth within our international professional liability and marine and energy product lines, as well as our personal lines and programs product lines, partially offset by lower premiums on our U.S. general liability and property product lines. Adjusted underwriting gross premium volume growth is a non-GAAP financial measure. See "Non-GAAP Financial Measures" for additional details.

The increase in fronting gross premium volume was driven by changes to our Hagerty relationship and Global Reinsurance division, as previously discussed, partially offset by lower premiums on our property catastrophe programs with Nephila driven by the impact of rate decreases, which is reflective of the broader property market.

Rates in the aggregate across our diversified product portfolio remained relatively flat in the first quarter of 2026 with various offsetting rate increases and decreases across different product lines. Product lines achieving the most notable rate increases include our U.S. personal lines and general liability product lines. Product lines with notable rate decreases include our U.S. property product lines and our international cyber and energy product lines, while we saw more moderate rate decreases on our U.S. workers' compensation product line. We examine each of our product classes regularly by evaluating pricing and exposure, underwriting terms and conditions, deal structure, including limits and attachment points, and our expectations around loss cost trends, among other things. We target premium growth only in product lines where we are confident in the levels of rate adequacy.

Net retention of underwriting gross premium volume for both the three months ended March 31, 2026 and 2025 was 80%. Net retention decreased due to the impact of the ceded written premiums within our Global Reinsurance division and with our Hagerty business related to previously written business that was reinsured during the first quarter, as previously discussed, as well as changes in mix of business due to the run off of the Global Reinsurance division, which had a higher retention ratio than the rest of the segment. These decreases were offset by the impact of our Hagerty business transitioning to a fronting arrangement in 2026, which we ceded at approximately 80% in 2025, as well as lower cessions on our professional liability and personal lines reinsurance contracts. Within our underwriting operations, we purchase reinsurance and retrocessional reinsurance to manage our net retention on individual risks and overall exposure to losses and to enable us to write policies with sufficient limits to meet policyholder needs.

The decrease in earned premiums for the three months ended March 31, 2026 was primarily due to the impact of the changes in gross premium volume and net retention in recent periods, as previously discussed.

<u>Combined Ratio</u>

Underwriting results for the three months ended March 31, 2026 included $35.0 million, or two points on the combined ratio, of net losses and loss adjustment expenses attributed to the Middle East conflict. Underwriting results for the three months ended March 31, 2025 included $66.1 million, or three points, of net losses and loss adjustment expenses attributed to the series of wildfires that occurred in southern California in January 2025. Excluding losses attributed to catastrophes, the decrease in the Markel Insurance segment combined ratio for the three months ended March 31, 2026 was primarily attributable to a lower attritional loss ratio, partially offset by less favorable development on prior accident years loss reserves.

The decrease in the attritional loss ratio for the three months ended March 31, 2026 was primarily attributable to lower attritional loss ratios across our international insurance products lines and our U.S. professional liability product lines, due in part to the benefit of exiting our risk-managed directors and officers product lines in 2025. Additionally, we recognized current accident year losses of $20.0 million on our discontinued IP CPI product line in the first quarter of 2025 compared to no such losses in the first quarter of 2026.

The combined ratio for the three months ended March 31, 2026 included $106.9 million of favorable development on prior accident years loss reserves compared to $148.8 million for the same period of 2025. The decrease in favorable development was primarily attributable to less favorable development on our professional liability and general liability insurance product lines. For the three months ended March 31, 2026, favorable development was most significant within our professional liability, credit and surety, and workers' compensation insurance product lines. Favorable development in the first quarter of 2025 was most significant on our professional liability, general liability, marine and energy, and workers' compensation insurance product lines.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

<u>Markel Insurance - Divisional Results</u>

The following tables present the divisional results of the Markel Insurance segment's underwriting and other insurance-related activities.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 |
| *<u>(dollars in thousands)</u>* | U.S. Wholesale and Specialty | Programs and Solutions | International | Global Reinsurance | Other | Markel Insurance |
| Gross premium volume - underwriting | $**672673** | $**655856** | $**860985** | $**22580** | $**3479** | $**2215573** |
| Gross premium volume - fronting | **—** | **510405** | **—** | **77017** | **—** | **587422** |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross premium volume | $**672673** | $**1166261** | $**860985** | $**99597** | $**3479** | $**2802995** |
| Net written premiums | $**588004** | $**499727** | $**713252** | $**(33234)** | $**3479** | $**1771228** |
| Earned premiums | $**628546** | $**567287** | $**608959** | $**160010** | $**4537** | $**1969339** |
| Losses and loss adjustment expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current accident year - attritional | **(389362)** | **(348161)** | **(320842)** | **(125977)** | **(1568)** | **(1185910)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Current accident year - catastrophe | **—** | **—** | **(35028)** | **—** | **—** | **(35028)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Prior accident years | **23190** | **35852** | **60510** | **(13853)** | **1240** | **106939** |
| Underwriting, acquisition, and insurance expenses | **(216058)** | **(201962)** | **(250433)** | **(42568)** | **(2070)** | **(713091)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Underwriting profit (loss) | $**46316** | $**53016** | $**63166** | $**(22388)** | $**2139** | $**142249** |
| Services and other revenues | $**—** | $**3340** | $**4364** | $**173** | $**194** | $**8071** |
| Services and other expenses | **—** | **(2386)** | **(722)** | **—** | **(1997)** | **(5105)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Services and other income (loss) | $**—** | $**954** | $**3642** | $**173** | $**(1803)** | $**2966** |
| Current accident year loss ratio | **61.9%** | **61.4%** | **58.4%** | **78.7%** |  | **62.0%** |
| Prior accident years loss ratio | **(3.7)%** | **(6.3)%** | **(9.9)%** | **8.7%** |  | **(5.4)%** |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss ratio | **58.3%** | **55.1%** | **48.5%** | **87.4%** |  | **56.6%** |
| Expense ratio | **34.4%** | **35.6%** | **41.1%** | **26.6%** |  | **36.2%** |
| &nbsp;&nbsp;&nbsp;&nbsp;Combined ratio | **92.6%** | **90.7%** | **89.6%** | **114.0%** |  | **92.8%** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 |
| *<u>(dollars in thousands)</u>* | U.S. Wholesale and Specialty | Programs and Solutions | International | Global Reinsurance | Other | Markel Insurance |
| Gross premium volume - underwriting | $742217 | $806228 | $670322 | $576928 | $(2289) | $2793406 |
| Gross premium volume - fronting |  | 378145 |  |  |  | 378145 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross premium volume | $742217 | $1184373 | $670322 | $576928 | $(2289) | $3171551 |
| Net written premiums | $605016 | $544843 | $572492 | $517102 | $(777) | $2238676 |
| Earned premiums | $662629 | $567245 | $509395 | $274248 | $3022 | $2016539 |
| Losses and loss adjustment expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current accident year - attritional | (457656) | (349767) | (278072) | (189859) | (20169) | (1295523) |
| &nbsp;&nbsp;&nbsp;&nbsp;Current accident year - catastrophe | (18167) | (15947) | (30000) | (1950) |  | (66064) |
| &nbsp;&nbsp;&nbsp;&nbsp;Prior accident years | 40526 | 22173 | 64636 | 17674 | 3828 | 148837 |
| Underwriting, acquisition, and insurance expenses | (225813) | (208051) | (209323) | (77455) | (2985) | (723627) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Underwriting profit (loss) | $1519 | $15653 | $56636 | $22658 | $(16304) | $80162 |
| Services and other revenues | $— | $3410 | $1097 | $— | $(203) | $4304 |
| Services and other expenses |  | (2440) | (2800) |  | (2944) | (8184) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Services and other income (loss) | $— | $970 | $(1703) | $— | $(3147) | $(3880) |
| Current accident year loss ratio | 71.8% | 64.5% | 60.5% | 69.9% |  | 67.5% |
| Prior accident years loss ratio | (6.1)% | (3.9)% | (12.7)% | (6.4)% |  | (7.4)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss ratio | 65.7% | 60.6% | 47.8% | 63.5% |  | 60.1% |
| Expense ratio | 34.1% | 36.7% | 41.1% | 28.2% |  | 35.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Combined ratio | 99.8% | 97.2% | 88.9% | 91.7% |  | 96.0% |

---

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

*U.S. Wholesale and Specialty*

The 9% decrease in gross premium volume and 5% decrease in earned premiums within the U.S. Wholesale and Specialty division for the three months ended March 31, 2026 were primarily due to certain underwriting actions taken within our general liability product lines aimed at improving overall profitability and rebalancing our product mix, as well as lower rates within our property product lines. The U.S. Wholesale and Specialty division's combined ratio for the three months ended March 31, 2026 decreased seven points primarily due to a lower current accident year loss ratio.

*Programs and Solutions*

The 19% decrease in underwriting gross premium volume within the Programs and Solutions division for the three months ended March 31, 2026 was primarily attributable to the transition of the Hagerty business to a fronting arrangement, partially offset by growth within our personal lines and programs product lines, as well as specialty lines written from our Bermuda platform. The 35% increase in fronting gross premium volume was driven by the transition of the Hagerty business to a fronting arrangement, partially offset by lower premiums on our property catastrophe programs with Nephila driven by rate decreases. The Programs and Solutions division's combined ratio for the three months ended March 31, 2026 decreased seven points primarily due to the impact of catastrophes losses in the first quarter of 2025 from the California wildfires and more favorable development on prior accident years loss reserves.

*International*

The 28% increase in gross premium volume and 20% increase in earned premiums within the International division for the three months ended March 31, 2026 were driven by increases on our professional liability and marine and energy product lines within the London market, as well as notable growth in Europe and Asia Pacific. The International division combined ratio was 90% in the first quarter of 2026, which included six points of net losses on the combined ratio attributed to the Middle East conflict.

*Global Reinsurance*

The 83% decrease in gross premium volume and 42% decrease in earned premiums within the Global Reinsurance division for the three months ended March 31, 2026 were attributable to the division entering run-off, as previously discussed. The Global Reinsurance division's combined ratio for the three months ended March 31, 2026 increased 22 points due to adverse development on prior accident years loss reserves compared to favorable development in the same period of 2025, as well as a higher attritional loss ratio, which we increased in response to recent loss development trends and to increase the level of caution in our loss reserves. Adverse development was driven by increases in prior accident years loss reserves within our general liability product lines due to greater severity than originally expected across older accident years.

**Industrial**

The Industrial segment is comprised of businesses that operate in the industrial sector. We measure the operating performance of our Industrial segment by its operating revenues and adjusted operating income, which represents operating income before amortization of acquired intangible assets. We consolidate the results of the businesses in the Industrial segment on a one-month lag, with the exception of significant transactions or events that occur during the intervening period. The following table summarizes the operating performance of our Industrial segment.

---

| | | | |
|:---|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
| *<u>(dollars in thousands)</u>* | **2026** | 2025 | % Change |
| Operating revenues | $**883058** | $829574 | 6% |
| Adjusted operating income | $**49286** | $58764 | (16)% |

---

The increase in operating revenues for the three months ended March 31, 2026 reflected organic growth and the contribution from an acquisition made by one of our businesses in December 2025. Organic revenue growth for our Industrial segment was 4% for the three months ended March 31, 2026. Organic revenue growth is a non-GAAP financial measure. See "Non-GAAP Financial Measures" for additional details.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

Organic revenue growth was primarily attributable to increased demand for our precast concrete products, resulting in higher prices and sales volume, as well as higher sales volume of our fire safety and equipment leasing services in the commercial construction industry. These increases were partially offset by lower sales volume of our car-hauling equipment due to a down cycle in demand for the industry.

The decrease in adjusted operating income for the three months ended March 31, 2026 was primarily attributable to a lower operating margin for the segment, due to changes in the mix of business, as previously discussed.

**Financial**

The Financial segment is comprised of insurance services and investment management businesses that operate in the financial sector, including State National and Nephila. We measure the operating performance of our Financial segment by its operating revenues and adjusted operating income, which represents operating income before amortization of acquired intangible assets. The following table summarizes the operating performance of our Financial segment.

---

| | | | |
|:---|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
| *<u>(dollars in thousands)</u>* | **2026** | 2025 | % Change |
| Operating revenues | $**161530** | $178481 | (9)% |
| Adjusted operating income | $**36205** | $79611 | (55)% |

---

The decrease in operating revenues for the three months ended March 31, 2026 was primarily attributable to the impact of $31.3 million of income related to our minority investment in Velocity Holdco, LLC (Velocity) in the first quarter of 2025 following the sale of its managing general agent operations, partially offset by 10% organic revenue growth.

Organic revenue growth was primarily attributable to higher management fees for our insurance-linked securities investment management services and higher premium volumes in recent periods for our program services and lender services offerings, partially offset by the impact of a $14.4 million impairment of an equity method investment in an asset management firm in the first quarter of 2026.

The decrease in adjusted operating income for the three months ended March 31, 2026 was primarily attributable to the impact of the income related to our minority investment in Velocity in 2025 and an impairment of an equity method investment in 2026, as previously discussed.

**Consumer and Other**

The Consumer and Other segment is comprised of businesses that operate in the consumer sector, as well as a variety of other sectors, including information technology, real estate, and healthcare. We measure the operating performance of our Consumer and Other segment by its operating revenues and adjusted operating income, which represents operating income before amortization of acquired intangible assets. We consolidate the results of the businesses in the Consumer and Other segment on a one-month lag, with the exception of significant transactions or events that occur during the intervening period. The following table summarizes the operating performance of our Consumer and Other segment.

---

| | | | |
|:---|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
| *<u>(dollars in thousands)</u>* | **2026** | 2025 | % Change |
| Operating revenues | $**280497** | $287786 | (3)% |
| Adjusted operating income | $**39755** | $32388 | 23% |

---

The decrease in operating revenues for the three months ended March 31, 2026 was driven by lower home sales volume, partially offset by the impact of a full quarter contribution from Educational Partners International (EPI), which we began consolidating in the first quarter of 2025. Organic revenues for our Consumer and Other segment declined by 6% for the three months ended March 31, 2026. The increase in adjusted operating income was driven by the increased contribution from EPI.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**Corporate**

The following table summarizes the results of our corporate operations, as well as a reconciliation to total corporate and eliminations as presented in the summary table of our consolidated results of operations. Our corporate operations include activities at our holding company, Markel Group Inc., and investments and loans to and from our operating businesses, which are held by other corporate subsidiaries. For further details of investment performance at our corporate operations, see "Consolidated Investment Results."

---

| | | |
|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, |
| *<u>(dollars in thousands)</u>* | **2026** | 2025 |
| Net investment income | $**29847** | $31616 |
| Other revenues | **6694** | 5033 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating revenues | **36541** | 36649 |
| Operating expenses <sup>(1)</sup> | **(20825)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate adjusted operating income | $**15716** | $36649 |
| Markel Group consolidating eliminations | **(12706)** | (10990) |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate and eliminations adjusted operating income | $**3010** | $25659 |

---

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Prior to the third quarter of 2025, corporate expenses were fully allocated to our segments.

**Consolidated Investment Results**

We measure our investment performance by analyzing net investment income, which reflects the recurring interest and dividend earnings on our investment portfolio. See note 3(d) of the notes to consolidated financial statements included under Item 1 for details regarding the components of net investment income.

We also analyze net investment gains, which are primarily comprised of unrealized gains and losses on our equity portfolio. Net investment gains or losses in any given period are typically attributable to changes in the fair value of our equity portfolio due to market value movements. Based on the potential for volatility in the financial markets, we understand that the level of gains or losses may vary from one period to the next, and therefore believe that our investment performance is best analyzed over longer periods of time. As of March 31, 2026, the fair value of our equity portfolio included cumulative unrealized gains of $8.2 billion.

The following table summarizes our consolidated investment performance. Investing results are attributed to our businesses based on the subsidiary that holds the investments.

---

| | | |
|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, |
| *<u>(dollars in thousands)</u>* | **2026** | 2025 |
| Net investment income | $**255890** | $237095 |
| Yield on fixed maturity securities <sup>(1)</sup> | **3.7%** | 3.5% |
| Yield on short-term investments <sup>(1)</sup> | **3.3%** | 3.8% |
| Yield on cash and cash equivalents and restricted cash and cash equivalents <sup>(1)</sup> | **2.8%** | 3.4% |
| Net realized investment gains (losses) | $**2043** | $(1801) |
| Change in fair value of equity securities | **(729605)** | (147270) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment losses | $**(727562)** | $(149071) |
| Return on equity securities <sup>(2)</sup> | **(5.2)%** | (0.9)% |

---

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Yield reflects the applicable annualized interest income as a percentage of the applicable monthly average invested assets at amortized cost.

<sup>(2)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Return on equity securities is calculated by dividing dividends and the change in fair value of equity securities by the monthly average equity securities at fair value and considers the timing of net purchases and sales.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

The 8% increase in net investment income for the three months ended March 31, 2026 was driven by higher interest income on fixed maturity securities and higher dividend income on equity securities due to higher yields and higher average holdings in 2026 compared to 2025. These increases were partially offset by lower interest income on cash and cash equivalents due to lower average cash and cash equivalents holdings and lower short-term interest rates in 2026 compared to 2025.

The following tables summarize the composition of our invested assets by segment. We hold investments across our operating businesses and at our holding company, with the majority of our investments held at our Markel Insurance business in support of its underwriting activities. Invested assets and the associated net investment income at our other reportable segments are primarily attributable to our Financial segment. Markel Insurance has also provided loans to a corporate subsidiary to fund certain non-insurance acquisitions. We evaluate these loan receivables similarly to invested assets held by Markel Insurance. Additionally, one of our corporate subsidiaries may, from time to time, provide loans to our operating businesses to fund strategic growth investments and projects. These intercompany loans are presented in the tables below but are eliminated in consolidation.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | March 31, 2026 | March 31, 2026 | March 31, 2026 | March 31, 2026 |
| *<u>(dollars in thousands)</u>* | Markel Insurance | Other Reportable Segments | Corporate | Total |
| Fixed maturity securities | $**17362079** | $**359488** | $**222214** | $**17943781** |
| Equity securities | **10332779** | **—** | **1969893** | **12302672** |
| Short-term investments | **763767** | **229139** | **1033241** | **2026147** |
| Cash and cash equivalents, including restricted | **2390260** | **893755** | **897263** | **4181278** |
| &nbsp;&nbsp;&nbsp;&nbsp;Invested assets | $**30848885** | $**1482382** | $**4122611** | $**36453878** |
| Intercompany loans receivable | $**728000** | $**—** | $**270637** |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | December 31, 2025 | December 31, 2025 | December 31, 2025 | December 31, 2025 |
| *<u>(dollars in thousands)</u>* | Markel Insurance | Other Reportable Segments | Corporate | Total |
| Fixed maturity securities | $17184810 | $371994 | $241182 | $17797986 |
| Equity securities | 10859200 |  | 2145112 | 13004312 |
| Short-term investments | 757540 | 229261 | 1046861 | 2033662 |
| Cash and cash equivalents, including restricted | 2526820 | 975829 | 1100653 | 4603302 |
| &nbsp;&nbsp;&nbsp;&nbsp;Invested assets | $31328370 | $1577084 | $4533808 | $37439262 |
| Intercompany loans receivable | $728000 | $— | $269176 |  |

---

The following tables summarize our investing results by segment. Intercompany interest relates to interest on intercompany loans.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2026 |
| *<u>(dollars in thousands)</u>* | Markel Insurance | Other Reportable Segments | Corporate | Eliminations | Total |
| Interest: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed maturity securities | $**159298** | $**2864** | $**2162** | $**—** | $**164324** |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term investments | **5774** | **1974** | **9356** | **—** | **17104** |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents, including restricted | **18670** | **4349** | **7937** | **—** | **30956** |
| &nbsp;&nbsp;&nbsp;&nbsp;Intercompany loans receivable | **6668** | **—** | **6038** | **(12706)** | **—** |
| Dividends on equity securities | **44053** | **—** | **5283** | **—** | **49336** |
| Investment expenses | **(4844)** | **(57)** | **(929)** | **—** | **(5830)** |
| Net investment income | $**229619** | $**9130** | $**29847** | $**(12706)** | $**255890** |
| Net investment gains (losses) | $**(553914)** | $**369** | $**(174017)** | $**—** | $**(727562)** |

---

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2025 |
| *<u>(dollars in thousands)</u>* | Markel Insurance | Other Reportable Segments | Corporate | Eliminations | Total |
| Interest: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed maturity securities | $140739 | $1485 | $1121 | $— | $143345 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term investments | 5655 | 2764 | 11254 |  | 19673 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents, including restricted | 24402 | 4762 | 10610 |  | 39774 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intercompany loans receivable | 7020 |  | 3970 | (10990) |  |
| Dividends on equity securities | 34532 |  | 5663 |  | 40195 |
| Investment expenses | (4831) | (59) | (1002) |  | (5892) |
| Net investment income | $207517 | $8952 | $31616 | $(10990) | $237095 |
| Net investment gains (losses) | $(224194) | $— | $75123 | $— | $(149071) |

---

**Consolidated Underwriting Reconciliation**

The following table reconciles our Markel Insurance segment underwriting results to our consolidated underwriting results. State National's underwriting results are included in our Financial segment.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
| | **2026** | **2026** | **2026** | **2026** | 2025 | 2025 | 2025 | 2025 |
| *<u>(dollars in thousands)</u>* | Markel Insurance | State National | Eliminations | Consolidated | Markel Insurance | State National | Eliminations | Consolidated |
| Gross premium volume: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Underwriting | $**2215573** | $**73655** | $**—** | $**2289228** | $2793406 | $71610 | $— | $2865016 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fronting | **587422** | **987748** | **(79376)** | **1495794** | 378145 | 1028666 | (53597) | 1353214 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $**2802995** | $**1061403** | $**(79376)** | $**3785022** | $3171551 | $1100276 | $(53597) | $4218230 |
| Earned premiums | $**1969339** | $**79547** | $**—** | $**2048886** | $2016539 | $72835 | $— | $2089374 |
| Losses and loss adjustment expenses | **(1113999)** | **(52818)** | **—** | **(1166817)** | (1212750) | (41915) |  | (1254665) |
| Underwriting, acquisition, and insurance expenses | **(713091)** | **(26737)** | **—** | **(739828)** | (723627) | (23811) |  | (747438) |
| &nbsp;&nbsp;&nbsp;&nbsp;Underwriting profit (loss) | $**142249** | $**(8)** | $**—** | $**142241** | $80162 | $7109 | $— | $87271 |
| Combined ratio | **92.8%** | **100.0%** |  | **93.1%** | 96.0% | 90.2% |  | 95.8% |

---

**Other**

The following table presents the components of consolidated net income that are not allocated to our operating segments.

---

| | | |
|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, |
| *<u>(dollars in thousands)</u>* | **2026** | 2025 |
| Amortization of acquired intangible assets | $**43513** | $46942 |
| Interest expense | $**50886** | $52140 |
| Net foreign exchange (gains) losses | $**(54277)** | $72633 |
| Income tax expense (benefit) | $**(65582)** | $28404 |
| Effective tax rate | **24%** | 18% |

---

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

<u>Net Foreign Exchange Gains and Losses</u>

Net foreign exchange gains and losses are primarily due to the remeasurement of our foreign currency denominated insurance loss reserves to the U.S. Dollar. The predominant foreign currencies within our insurance operations are the Euro and the British Pound. The U.S. Dollar strengthened against the Euro and the British Pound during the three months ended March 31, 2026, while it weakened against these currencies during the same period of 2025.

Our exposure to foreign currency exchange rates is largely hedged through our available-for-sale investment portfolio, where we hold securities that generally match the currencies of our loss reserves. We also purchase foreign currency forward contracts to manage unmatched foreign currency exposures.

Pre-tax net foreign exchange gains and losses attributed to changes in exchange rates on available-for-sale securities supporting our insurance reserves, which are included in the changes in net unrealized losses on available-for-sale investments in other comprehensive income, were losses of $51.8 million for the three months ended March 31, 2026 compared to gains of $64.4 million for the same period of 2025.

<u>Income Taxes</u>

The effective tax rate was 24% and 18% for the three months ended March 31, 2026 and 2025, respectively. The effective tax rate for 2026 and 2025 differs from the statutory rate of 21%, primarily due to various immaterial discrete items that resulted in a net tax benefit in the quarter, the impact of which was magnified due to the relatively small pre-tax loss in the first quarter of 2026 and pre-tax income in the first quarter of 2025.

We use the estimated annual effective tax rate method for calculating our tax provision in interim periods. This method applies our best estimate of the effective tax rate expected for the full year to year-to-date earnings before income taxes. Certain items, including those deemed to be unusual, infrequent or that cannot be reliably estimated (discrete items), are excluded from the estimated annual effective tax rate, and the related tax expense or benefit is reported in the same period as the related item. The estimated annual effective tax rate was 21% and 22% for the three months ended March 31, 2026 and 2025, respectively.

**Other Comprehensive Income (Loss) to Shareholders**

The following table summarizes the components of other comprehensive income (loss) to shareholders.

---

| | | |
|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, |
| *<u>(dollars in thousands)</u>* | **2026** | 2025 |
| Change in net unrealized losses on available-for-sale investments, net of taxes | $**(133821)** | $218377 |
| Other, net of taxes | **5717** | 7552 |
| Other comprehensive (income) loss attributable to noncontrolling interests | **(37)** | 27 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) to shareholders | $**(128141)** | $225956 |

---

The change in net unrealized losses on available-for-sale investments in any given period is typically attributable to changes in the fair value of our fixed maturity portfolio due to changes in interest rates during the period, and, to a lesser extent, changes in foreign currency exchange rates.

As of March 31, 2026, 97% of our fixed maturity portfolio was rated "AA" or better.

**<u>Financial Condition</u>**

**Liquidity and Capital Resources**

We seek to maintain prudent levels of liquidity and financial leverage for the benefit and protection of our policyholders, creditors, and shareholders. Our consolidated debt to capital ratio was 19% at both March 31, 2026 and December 31, 2025, which is within the range of our target capital structure.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

Investments, cash and cash equivalents, and restricted cash and cash equivalents (invested assets) were $36.5 billion and $37.4 billion at March 31, 2026 and December 31, 2025, respectively. The decrease in invested assets was primarily attributable to a decrease in the fair value of our equity securities. Our holding company had $4.0 billion and $4.4 billion of invested assets at March 31, 2026 and December 31, 2025, respectively. The decrease in invested assets at our holding company was primarily attributable to a decrease in the fair value of equity securities held by our holding company and cash used to repurchase shares of our common stock. For further details on the composition of our invested assets, see "Consolidated Investment Results."

We have a share repurchase program, authorized by our Board of Directors, that provides for the repurchase of up to $2 billion of common stock. As of March 31, 2026, $1.4 billion remained available for repurchase under the program. This share repurchase program has no expiration date but may be terminated by the Board of Directors at any time.

We may from time to time seek to prepay, retire, or repurchase our outstanding senior notes, through open market purchases, privately negotiated transactions, or otherwise. Those prepayments, retirements, or repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions, and other factors.

We have access to various capital sources, including dividends from our subsidiaries, holding company invested assets, undrawn capacity under our revolving credit facility, and access to the debt and equity capital markets. We believe we have, or have access to, adequate liquidity to meet our capital and operating needs, including that which may be required to support the operating needs of our subsidiaries. However, the availability of these sources of capital and the availability and terms of future financings will depend on a variety of factors.

**Cash Flows**

Net cash provided by operating activities was $15.9 million for the three months ended March 31, 2026 compared to $376.2 million for the same period of 2025. The decrease was primarily attributable to higher net claims payments and lower net premiums collected within our Markel Insurance Segment, due in part to net payments made in the first quarter of 2026 totaling $107.7 million to reinsure our exposures on our Hagerty business following the transition of that business to a fronting arrangement in 2026. Lower premium collections in 2026 also reflect the impact of lower premium volume due to the run off of our Global Reinsurance division. The decrease in operating cash flows was also attributable to lower cash flows from our Financial and Industrial segments and higher net tax payments in the first quarter of 2026.

Net cash used by investing activities was $348.2 million for the three months ended March 31, 2026 compared to net cash provided by investing activities of $192.8 million for the same period of 2025. During the three months ended March 31, 2026, net cash used by investing activities included net purchases of fixed maturity securities and equity securities of $271.6 million and $28.0 million, respectively. During the three months ended March 31, 2025, net cash provided by investing activities included net sales of short-term investments of $447.4 million and net purchases of fixed maturity securities and equity securities of $242.2 million and $56.7 million, respectively. Cash flows from investing activities are affected by various factors such as anticipated payment of claims, financing activity, acquisition opportunities, and individual buy and sell decisions made in the normal course of our investment portfolio management.

Net cash used by financing activities was $79.5 million for the three months ended March 31, 2026 compared to $105.8 million for the same period of 2025. Cash of $133.9 million and $170.3 million was used to repurchase shares of our common stock during the first three months of 2026 and 2025, respectively. Additionally, financing activities during the three months ended March 31, 2026 and 2025 reflected borrowings and repayments of debt at certain of our operating businesses, primarily on revolving lines of credit.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**<u>Non-GAAP Financial Measures</u>**

Markel Group utilizes certain non-GAAP measures that we believe enhance the understanding of our performance. These measures should not be viewed as a substitute for measures determined in accordance with U.S. GAAP.

**Consolidated Adjusted Operating Income**

Consolidated adjusted operating income, which excludes net investment gains and losses, amortization of acquired intangible assets, and impairment of goodwill, is a non-GAAP financial measure. We believe adjusted operating income is generally an accurate representation of the operating performance of our businesses in our periodic results. Net investment gains and losses are predominantly derived from our investments in publicly traded equity securities and include significant unrealized gains and losses from market value movements. We believe that net investment gains and losses, whether realized from sales or unrealized from market value movements, are distortive in understanding the short-term operating performance of our businesses. We do not view amortization of intangible assets and impairment of goodwill, which arise from purchase accounting for acquisitions, as ongoing costs of operating our businesses, and therefore exclude those amounts from our adjusted operating income metric.

**Combined Ratio and Current Accident Year Loss Ratio, Excluding Current Year Catastrophe Events**

We use underwriting profit or loss and the combined ratio as a basis for evaluating our underwriting performance. The U.S. GAAP combined ratio is a measure of underwriting performance and represents the relationship of incurred losses, loss adjustment expenses, and underwriting, acquisition, and insurance expenses to earned premiums. The combined ratio is the sum of the loss ratio and the expense ratio.

When analyzing our loss ratio, we typically evaluate losses and loss adjustment expenses attributable to the current accident year separately from losses and loss adjustment expenses attributable to prior accident years. Prior accident year reserve development, which can either be favorable or unfavorable, represents changes in our estimates of losses and loss adjustment expenses related to loss events that occurred in prior years. We believe a discussion of the current accident year loss ratio that excludes prior accident year reserve development is helpful in most cases since it provides more insight into estimates of current underwriting performance and excludes changes in estimates related to prior year loss reserves.

In addition to the U.S. GAAP combined ratio, loss ratio, and expense ratio, we also evaluate our underwriting performance using measures that exclude the impacts of certain items on these ratios. We believe these adjusted measures, which are non-GAAP measures, provide financial statement users with a better understanding of the significant factors that comprise our underwriting results and how management evaluates underwriting performance.

When analyzing our combined ratio, we exclude current accident year losses and loss adjustment expenses attributed to natural catastrophes and certain other significant, infrequent loss events, such as the Middle East conflict. Gross and ceded losses for certain events may also result in receipt or payment of reinstatement premiums, which, if significant, may also be excluded when analyzing our combined ratio. Due to the unique characteristics of these events, there is inherent variability as to the timing and amount of the loss, which cannot be predicted in advance. We believe measures that exclude the effects of such events are meaningful to understand the underlying trends and variability in our underwriting results that may be obscured by these items.

We also analyze our current accident year loss ratio excluding losses and loss adjustment expenses attributable to catastrophes and other significant, infrequent loss events. The current accident year loss ratio excluding the impact of catastrophes and other significant, infrequent loss events is commonly referred to as an attritional loss ratio within the property and casualty insurance industry.

The components of Markel Insurance's combined ratios, including these non-GAAP measures, are included in "Markel Insurance".

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**Adjusted Underwriting Gross Premium Volume**

Adjusted underwriting gross premium volume is a non-GAAP measure that excludes underwriting gross premium volume from the Global Reinsurance division and our business with Hagerty for both periods. In August 2025, Markel Insurance sold the renewal rights for contracts written through its Global Reinsurance division, and the division entered into run-off, which resulted in a significant decline in underwriting gross premium volume. Beginning on January 1, 2026, Markel Insurance's business written on behalf of Hagerty transitioned from being an underwriting product to a fronting arrangement, which resulted in a change in the presentation of the related gross premium volume and therefore, a significant decline in underwriting gross premium volume. We believe adjusted underwriting gross premium volume is a meaningful measure when comparing underwriting gross premium volume from period-to-period as it adjusts for the impact of these significant contractual restructuring changes within the Markel Insurance segment. The following table reconciles underwriting gross premium volume to adjusted underwriting gross premium volume.

---

| | | | |
|:---|:---|:---|:---|
| | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
| *<u>(dollars in thousands)</u>* | 2026 | 2025 | % Change |
| Underwriting gross premium volume | $2215573 | $2793406 | (21)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Global Reinsurance division underwriting gross premium volume | 22580 | 576928 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Hagerty underwriting gross premium volume |  | 219927 |  |
| Adjusted underwriting gross premium volume | $2192993 | $1996551 | 10% |

---

**Organic Revenue Growth**

Organic revenue growth is a non-GAAP measure. We believe organic revenue growth is a meaningful measure as it provides growth in comparable revenues from period-to-period by adjusting for the impact of acquisitions and dispositions. For acquisitions and dispositions, the calculation of organic revenue growth excludes the revenue of the business from the two periods being compared unless our consolidated results include a full period of revenue from the business for both periods. The following table reconciles revenue growth to organic revenue growth.

---

| | |
|:---|:---|
| | Three Months Ended March 31, 2026 |
| **Industrial segment:** |  |
| Revenue growth | 6.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Impact of inorganic activity | (2.2)% |
| Organic revenue growth | 4.2% |
| **Financial segment:** |  |
| Revenue growth | (9.5)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Impact of inorganic activity | 19.2% |
| Organic revenue growth | 9.7% |
| **Consumer and Other segment:** |  |
| Revenue growth | (2.5)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Impact of inorganic activity | (3.4)% |
| Organic revenue growth | (5.9)% |

---

**<u>Critical Accounting Estimates</u>** 

Critical accounting estimates are those estimates that both are important to the portrayal of our financial condition and results of operations and require us to exercise significant judgment. The preparation of financial statements in accordance with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of material contingent assets and liabilities. These estimates, by necessity, are based on assumptions about numerous factors.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

Our critical accounting estimates consist of estimates and assumptions used in determining the reserves for unpaid losses and loss adjustment expenses as well as estimates and assumptions used in the valuation of goodwill and intangible assets. We review the adequacy of reserves for unpaid losses and loss adjustment expenses quarterly. Estimates and assumptions for goodwill and intangible assets are reviewed in conjunction with acquisitions and impairment assessments. Goodwill and indefinite-lived intangible assets are reassessed for impairment at least annually. All intangible assets, including goodwill, are also reviewed for impairment when events or circumstances indicate that their carrying value may not be recoverable. Actual results may differ materially from the estimates and assumptions used in preparing the consolidated financial statements.

Readers are urged to review our 2025 Annual Report on Form 10-K for a more complete description of our critical accounting estimates.

**<u>Safe Harbor and Cautionary Statement</u>**

This report contains statements concerning or incorporating our expectations, assumptions, plans, objectives, future financial or operating performance and other statements that are not historical facts. These statements are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may use words such as "anticipate," "believe," "estimate," "expect," "intend," "predict," "project," and similar expressions as they relate to us or our management.

There are risks and uncertainties that may cause actual results to differ materially from predicted results in forward-looking statements. Factors that may cause actual results to differ are often presented with the forward-looking statements themselves. Additional factors that could cause actual results to differ from those predicted are set forth under Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis of Financial Condition and Results of Operations, and Item 7A Quantitative and Qualitative Disclosures About Market Risk in our 2025 Annual Report on Form 10-K or under "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Quantitative and Qualitative Disclosures About Market Risk," and "Risk Factors" in this report, or are included in the items listed below:

• the effect of cyclical trends or changes in market conditions on our operations, including demand and pricing in the markets in which we operate;

• actions by competitors, including the use of technology (e.g., artificial intelligence) and innovation to simplify the customer experience, increase efficiencies, redesign products, alter models, and effect other potentially disruptive changes, and the effect of competition on market trends and pricing;

• our efforts to develop new products, expand in targeted markets, or improve business processes and workflows, including through the use of artificial intelligence, may not be successful, may cost more, or take longer than expected and may increase or create new risks (e.g., insufficient demand, change to risk exposures, distribution channel conflicts, execution risk, regulatory risk, increased expenditures);

• the frequency and severity of natural, health-related, and man-made catastrophes, including regional or military conflicts, may exceed expectations, are unpredictable and, in the case of some natural catastrophes, may be exacerbated by changing conditions in the climate, oceans and atmosphere, resulting in increased frequency and/or severity of extreme weather-related events;

• we offer coverage against terrorist acts in connection with some of our programs, and in other instances we are legally required to offer terrorism insurance; in both circumstances, we actively manage our exposure, but if there is a covered terrorist attack, we could sustain material losses;

• emerging claim and coverage issues, changing industry practices, and evolving legal, judicial, social, and other claims, and coverage trends or conditions, can increase the scope of coverage, the frequency and severity of claims, and the period over which claims may be reported; these factors, as well as uncertainties in the loss estimation process, can adversely impact the adequacy of our loss reserves and our allowance for reinsurance recoverables;

• reserves for our run-off reinsurance business are subject to greater uncertainty than insurance reserves, primarily because of reliance upon the original underwriting decisions made by ceding companies and the longer lapse of time from the occurrence of loss events to their reporting to the reinsurer for ultimate resolution;

• failures, inadequacies, or inaccuracies (whether due to data error, human error, or otherwise) in the various methods, modeling techniques, and data analytics (e.g., scenarios, predictive and stochastic modeling, and forecasting) we use to analyze and estimate exposures, loss trends, and other risks associated with our insurance businesses could cause us to misprice our products or fail to appropriately estimate the risks to which we are exposed;

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

• changes in the assumptions and estimates used in establishing reserves for our life and annuity reinsurance book (which is in run-off), for example, changes in assumptions and estimates of mortality, longevity, morbidity, and interest rates, could result in material changes in our estimated loss reserves for that business;

• adverse developments in insurance coverage litigation or other legal or administrative proceedings could result in material increases in our estimates of loss reserves;

• initial loss estimates for catastrophes and other significant, infrequent loss events are often based on limited information, are dependent on broad assumptions about the nature and extent of losses, coverage, liability and reinsurance, and those losses may ultimately differ materially from our expectations;

• changes in the availability, costs, quality, and providers of reinsurance coverage, which may impact our ability to write, or continue to write, certain lines of business or to mitigate the volatility of losses on our results of operations and financial condition;

• the ability or willingness of reinsurers to pay balances due may be adversely affected by industry and economic conditions, deterioration in reinsurer credit quality and coverage disputes, and collateral we hold, if any, may not be sufficient to cover a reinsurer's obligation to us;

• regulatory actions affecting our insurance companies can impede our ability to charge adequate rates and efficiently allocate capital;

• general economic and market conditions and industry specific conditions, including: extended economic recessions or expansions; prolonged periods of slow economic growth; inflation or deflation; significant fluctuations in foreign currency exchange rates, commodity and energy prices, and interest rates; volatility in the credit and capital markets; the imposition of duties, tariffs and other changes in international trade regulation, and other factors;

• economic conditions, actual or potential defaults in corporate bonds, municipal bonds, mortgage-backed securities or sovereign debt obligations, volatility in interest and foreign currency exchange rates, changes in U.S. government debt ratings, and changes in market value of concentrated investments can have a significant impact on the fair value of our fixed maturity securities and equity securities, as well as the carrying value of our other assets and liabilities, and this impact may be heightened by market volatility and our ability to mitigate our sensitivity to these changing conditions;

• the effects of government intervention, including material changes in the monetary policies of central banks, to address financial downturns, inflation, and other economic and currency concerns;

• the impacts that political and civil unrest and regional and military conflicts may have on our businesses and the markets they serve or that any disruptions in regional or worldwide economic conditions generally arising from these situations may have on our businesses, industries, or investments;

• the impacts of liability, transition, and physical risks associated with climate change;

• the significant volatility, uncertainty, and disruption caused by health epidemics and pandemics, as well as governmental, legislative, judicial, or regulatory actions or developments in response thereto;

• changes in U.S. tax laws, regulations, or interpretations, or in the tax laws, regulations, or interpretations of other jurisdictions in which we operate, and adjustments we may make in our operations or tax strategies in response to those changes;

• a failure or security breach of, or cyberattack on, enterprise information technology systems that we, or third parties who perform certain functions for us, use, or a failure to comply with data protection or privacy regulations or regulations related to the use of artificial intelligence or machine learning technology;

• third-party providers may perform poorly, breach their obligations to us, or expose us to enhanced risks;

• our acquisitions may increase our operational and internal control risks for a period of time;

• we may not realize the contemplated benefits, including cost savings and synergies, of our acquisitions;

• any developments requiring the write-off of a significant portion of our goodwill and intangible assets;

• the loss of services of any senior executive or other key personnel, or an inability to attract and retain qualified leaders to run any of our businesses could adversely impact one or more of our operations;

• the decentralized manner in which our businesses operate through independent local management teams could result in inconsistent management, governance, and oversight practices;

• our substantial international operations and investments expose us to increased political, civil, operational, and economic risks, including foreign currency exchange rate and credit risk;

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

• our ability to obtain additional capital for our operations on terms favorable to us;

• economic conditions, which may adversely affect our access to capital and credit markets;

• the compliance, or failure to comply, with covenants and other requirements under our credit facilities, senior debt, and other indebtedness;

• our ability to maintain or raise third-party capital for existing or new investment vehicles and risks related to our management of third-party capital;

• the effectiveness of our procedures for compliance with existing and future guidelines, policies, and legal and regulatory standards, rules, laws, and regulations;

• the impact of economic and trade sanctions and embargo programs on our businesses, including instances in which the requirements and limitations imposed on the global operations of our companies by one or more jurisdictions are more restrictive than, or conflict with, applicable requirements and limitations imposed by other jurisdictions;

• regulatory changes or challenges by regulators, including regarding the use of certain issuing carrier or fronting arrangements;

• our dependence on a limited number of brokers for a large portion of our insurance revenues;

• adverse changes in our assigned financial strength or debt ratings, or outlook, could adversely impact us, including our ability to attract and retain business, the amount of capital our insurance subsidiaries must hold, and the availability and cost of capital;

• changes in the amount of statutory capital our insurance subsidiaries are required to hold, which can vary significantly and is based on many factors, some of which are outside our control;

• market fluctuations in the value of the equity securities we hold, both at our insurance subsidiaries and our holding company, can significantly impact our periodic results and the amount of statutory capital our insurance subsidiaries are required to hold;

• losses from litigation and regulatory investigations and actions;

• disruptions resulting from a threatened proxy contest or other actions by activist shareholders;

• considerations and limitations relating to the use of growth in intrinsic value as a performance metric, including the possibility that shareholders, analysts, or other market participants may have a different perception of our intrinsic value, which may result in growth in our stock price varying significantly from our growth in intrinsic value calculations; and

**•** a number of additional factors may adversely affect our Industrial, Financial, and Consumer and Other businesses, and the markets they serve, and negatively impact their revenues and profitability, including, among others: adverse weather conditions, plant disease, and other contaminants; changes in government support for education, healthcare, and infrastructure projects; changes in capital spending levels; changes in the housing, commercial, and industrial construction markets; liability for environmental matters; supply chain and shipping issues, including increases in freight costs; volatility in the market prices for their products; and volatility in commodity, wholesale, and raw materials prices, and interest and foreign currency exchange rates.

Results from our operations have been and will continue to be potentially materially affected by these factors.

By making forward-looking statements, we do not intend to become obligated to publicly update or revise any such statements whether as a result of new information, future events, or other changes. Readers are cautioned not to place undue reliance on any forward-looking statements, which are based on our current knowledge and speak only as at their dates.

**Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

Market risk is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument as the result of changes in equity prices, interest rates, foreign currency exchange rates, and commodity prices. Our consolidated balance sheets include assets and liabilities with estimated fair values that are subject to market risk. Our primary market risks are equity price risk associated with investments in equity securities, interest rate risk associated with investments in fixed maturity securities and foreign currency exchange rate risk associated with our international operations. During the three months ended March 31, 2026, there were no material changes in our market risk exposures from those described in our 2025 Annual Report on Form 10-K.

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

**<u>Credit Risk</u>**

Credit risk, which is not considered a market risk, is the risk that an entity becomes unable or unwilling to fulfill its obligations to us. Our primary credit risks are the credit risk within our fixed maturity portfolio and the credit risk related to our reinsurance recoverables. For the three months ended March 31, 2026, no material credit losses or potential credit losses were identified, thus there were no material changes in our credit risk exposures from those described in our 2025 Annual Report on Form 10-K.

**Item 4. CONTROLS AND PROCEDURES**

**<u>Evaluation of Disclosure Controls and Procedures</u>**

As of the end of the period covered by this quarterly report, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (Disclosure Controls), as defined under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (Exchange Act). This evaluation was conducted under the supervision and with the participation of our management, including the Principal Executive Officer (PEO) and the Principal Financial Officer (PFO).

Based upon this evaluation, the PEO and PFO concluded that effective Disclosure Controls were in place to ensure that the information required to be disclosed in reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission's rules and forms.

**<u>Changes in Internal Control over Financial Reporting</u>**

There were no changes in our internal control over financial reporting during the first quarter of 2026 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**PART II. OTHER INFORMATION**

**Item 1A. RISK FACTORS**

The disclosure below supplements risk factors previously disclosed in our 2025 Annual Report on Form 10-K. These risks and uncertainties, along with those previously disclosed, could materially adversely affect our businesses, results of operations, or financial condition.

**Our businesses, results of operations, and financial condition could be adversely affected by ongoing regional or military conflicts and related disruptions in the global economy.** The global economy has been, and may in the future be, negatively impacted by regional or military conflicts, for example, the on-going conflicts between Russia and Ukraine and in the Middle East, following U.S. and Israeli airstrikes on Iran. We may have operations in areas affected by a conflict, and some of our businesses may be adversely affected by a conflict and its effects. Within our underwriting operations, we have, and may continue to have, insurance contracts with exposure to losses attributed or corollary to a conflict, such as losses related to our coverage of ships, cargo, trade credit, and inventory. For example, we underwrite insurance policies covering risks in the Middle East and have incurred losses from the Middle East conflict attributed to terrorism and marine war coverages written by the Markel Insurance International division, which we discuss under Item 2 Management's Discussion & Analysis of Financial Condition and Results of Operations. Additionally, our investment portfolio has experienced, and may continue to experience, adverse market value movements attributable to market reactions to developments in the Middle East, including fluctuations in energy prices, and broader equity and fixed income market volatility. Our other operations also may have direct exposure to customers and vendors in an affected area. Certain of our businesses may experience shortages in materials and increased costs for transportation, energy, and raw materials due in part to the negative impact of a conflict on the global economy.

Furthermore, governments in the U.S., U.K., and E.U., among others, may impose export controls on certain products and financial and economic sanctions on certain industry sectors and parties in affected areas. These export controls and sanctions, or our failure to comply with them, could result in restrictions on our ability to do business in one or more of the jurisdictions in which we conduct business or have the other adverse effects previously discussed in our 2025 Annual Report on Form 10-K in Item 1A Risk Factors under "We are subject to laws and regulations relating to economic and trade sanctions and bribery and corruption, the violation of which could have a material adverse effect on us."

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

We are unable to predict the impact an ongoing conflict may have on our businesses or the global economy. The impact of geopolitical tensions related to these conflicts, including increased trade barriers or restrictions on global trade, is unknown and could result in, among other things, heightened cybersecurity threats, supply disruptions, disruptions to our operations, protracted or increased inflation, increased energy costs, lower consumer demand, fluctuations in interest and foreign exchange rates, and increased volatility in financial markets, any of which could adversely affect our businesses, results of operations, and financial condition. In addition, an ongoing conflict may have the effect of triggering or intensifying many of the risks described in Part I, Item 1A Risk Factors of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

**Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

The following table summarizes our common share repurchases for the quarter ended March 31, 2026.

---

| | | | | |
|:---|:---|:---|:---|:---|
| Issuer Purchases of Equity Securities | Issuer Purchases of Equity Securities | Issuer Purchases of Equity Securities | Issuer Purchases of Equity Securities | Issuer Purchases of Equity Securities |
|  | (a) | (b) | (c) | (d) |
|  | Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs<sup>(1)</sup> | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in thousands) |
| January 1, 2026 through January 31, 2026 | **13655** | $**2078.69** | **13655** | $**1469143** |
| February 1, 2026 through February 28, 2026 | **23627** | $**2072.53** | **23627** | $**1420175** |
| March 1, 2026 through March 31, 2026 | **25955** | $**1938.33** | **25955** | $**1369866** |
| Total | **63237** | $**2018.78** | **63237** | $**1369866** |

---

<sup>(1)&nbsp;&nbsp;&nbsp;&nbsp;</sup>The Board of Directors approved the repurchase of up to $2 billion of our common shares pursuant to a share repurchase program publicly announced in November 2024. Under our share repurchase program, we may repurchase outstanding common shares of our stock from time to time in privately negotiated or open market transactions, including under plans complying with Rule 10b5-1 and Rule 10b-18 under the Securities Exchange Act of 1934. The share repurchase program has no expiration date but may be terminated by the Board at any time.

**Item 5. OTHER INFORMATION**

**<u>Adoption or Termination of Trading Arrangements by Directors or Officers</u>**

During the Company's quarterly period ended March 31, 2026, no director or officer (as defined in Exchange Act Rule 16a-1(f)) of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" as defined in Regulation S-K Item 408.

**Item 6. EXHIBITS**

---

| | |
|:---|:---|
| <u>Exhibit No.</u> | <u>Document Description</u> |
| <u>[3.1](https://www.sec.gov/Archives/edgar/data/1096343/000109634325000093/mklararticlesofincorporati.htm)</u> | <u>[Amended and Restated Articles of Incorporation (incorporated by reference from Exhibit 3.1 in the Registrant's report on Form 8-K filed with the Commission June 4, 2025)](https://www.sec.gov/Archives/edgar/data/1096343/000109634325000093/mklararticlesofincorporati.htm)</u> |
| <u>[3.2](https://www.sec.gov/Archives/edgar/data/1096343/000109634326000018/mklarbylaws2262026.htm)</u> | <u>[Bylaws, as amended and restated](https://www.sec.gov/Archives/edgar/data/1096343/000109634326000018/mklarbylaws2262026.htm)[February 25, 2026](https://www.sec.gov/Archives/edgar/data/1096343/000109634326000018/mklarbylaws2262026.htm)[(incorporated by reference from Exhibit 3.](https://www.sec.gov/Archives/edgar/data/1096343/000109634326000018/mklarbylaws2262026.htm)[1](https://www.sec.gov/Archives/edgar/data/1096343/000109634326000018/mklarbylaws2262026.htm)[in the Registrant's report on Form](https://www.sec.gov/Archives/edgar/data/1096343/000109634326000018/mklarbylaws2262026.htm)[8](https://www.sec.gov/Archives/edgar/data/1096343/000109634326000018/mklarbylaws2262026.htm)[-](https://www.sec.gov/Archives/edgar/data/1096343/000109634326000018/mklarbylaws2262026.htm)[K](https://www.sec.gov/Archives/edgar/data/1096343/000109634326000018/mklarbylaws2262026.htm)[filed with the Commission](https://www.sec.gov/Archives/edgar/data/1096343/000109634326000018/mklarbylaws2262026.htm)[February 26, 2026](https://www.sec.gov/Archives/edgar/data/1096343/000109634326000018/mklarbylaws2262026.htm)[)](https://www.sec.gov/Archives/edgar/data/1096343/000109634326000018/mklarbylaws2262026.htm)</u> |
| <u>[4.1(a)](https://www.sec.gov/Archives/edgar/data/1096343/000091664101500514/dex41.txt)</u> | <u>[Indenture dated as of June 5, 2001, between Markel Corporation and The Chase Manhattan Bank, as Trustee (incorporated by reference from Exhibit 4.1 in the Registrant's report on Form 8-K filed with the Commission June 5, 2001)](https://www.sec.gov/Archives/edgar/data/1096343/000091664101500514/dex41.txt)</u>  |
| <u>[4.1(b)](https://www.sec.gov/Archives/edgar/data/1096343/000119312504137837/dex42.htm)</u> | <u>[Form of Third Supplemental Indenture dated as of August 13, 2004, between Markel Corporation and JPMorgan Chase Bank (formerly known as The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (incorporated by reference from Exhibit 4.2 in the Registrant's report on Form 8-K filed with the Commission August 11, 2004)](https://www.sec.gov/Archives/edgar/data/1096343/000119312504137837/dex42.htm)</u> |
| <u>[4.1(c)](https://www.sec.gov/Archives/edgar/data/1096343/000119312513096007/d497508dex43.htm)</u> | <u>[Form of Ninth Supplemental Indenture dated as of March 8, 2013, between Markel Corporation and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (incorporated by reference from Exhibit 4.3 in the Registrant's report on Form 8-K filed with the Commission March 7, 2013)](https://www.sec.gov/Archives/edgar/data/1096343/000119312513096007/d497508dex43.htm)</u> |

---

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

---

| | |
|:---|:---|
| <u>[4.1(d)](https://www.sec.gov/Archives/edgar/data/1096343/000109634316000213/ex42tenthsupplementalinden.htm)</u> | <u>[Form of Tenth Supplemental Indenture dated as of April 5, 2016, between Markel Corporation and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (incorporated by reference from Exhibit 4.2 in the Registrant's report on Form 8-K filed with the Commission March 31, 2016)](https://www.sec.gov/Archives/edgar/data/1096343/000109634316000213/ex42tenthsupplementalinden.htm)</u> |
| <u>[4.1(e)](https://www.sec.gov/Archives/edgar/data/1096343/000109634317000159/mkl11022017exhibit42.htm)</u> | <u>[Eleventh Supplemental Indenture dated as of November 2, 2017, between Markel Corporation and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (incorporated by reference from Exhibit 4.2 in the Registrant's report on Form 8-K filed with the Commission November 2, 2017)](https://www.sec.gov/Archives/edgar/data/1096343/000109634317000159/mkl11022017exhibit42.htm)</u> |
| <u>[4.1(f)](https://www.sec.gov/Archives/edgar/data/1096343/000109634317000159/mkl11022017exhibit43.htm)</u> | <u>[Twelfth Supplemental Indenture dated as of November 2, 2017, between Markel Corporation and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (incorporated by reference from Exhibit 4.3 in the Registrant's report on Form 8-K filed with the Commission November 2, 2017)](https://www.sec.gov/Archives/edgar/data/1096343/000109634317000159/mkl11022017exhibit43.htm)</u> |
| <u>[4.1(g)](https://www.sec.gov/Archives/edgar/data/1096343/000109634319000146/exh42-mklx13thsupplemental.htm)</u> | <u>[Thirteenth Supplemental Indenture, dated as of May 20, 2019, between Markel Corporation and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (incorporated by reference from Exhibit 4.2 in the Registrant's report on Form 8-K filed with the Commission May 20, 2019)](https://www.sec.gov/Archives/edgar/data/1096343/000109634319000146/exh42-mklx13thsupplemental.htm)</u> |
| <u>[4.1(h)](https://www.sec.gov/Archives/edgar/data/1096343/000109634319000186/exh42-markelxsept2019notes.htm)</u> | <u>[Fourteenth Supplemental Indenture, dated as of September 17, 2019, between Markel Corporation and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (incorporated by reference from Exhibit 4.2 in the Registrant's report on Form 8-K filed with the Commission September 17, 2019)](https://www.sec.gov/Archives/edgar/data/1096343/000109634319000186/exh42-markelxsept2019notes.htm)</u> |
| <u>[4.1(i)](https://www.sec.gov/Archives/edgar/data/1096343/000109634319000186/exh43-markelxsept2019notes.htm)</u> | <u>[Fifteenth Supplemental Indenture, dated as of September 17, 2019, between Markel Corporation and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (incorporated by reference from Exhibit 4.3 in the Registrant's report on Form 8-K filed with the Commission September 17, 2019)](https://www.sec.gov/Archives/edgar/data/1096343/000109634319000186/exh43-markelxsept2019notes.htm)</u> |
| <u>[4.1(j)](https://www.sec.gov/Archives/edgar/data/1096343/000109634321000079/mkl05072021ex42.htm)</u> | <u>[Sixteenth Supplemental Indenture, dated as of May 7, 2021, between Markel Corporation and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (incorporated by reference from Exhibit 4.2 in the Registrant's report on Form 8-K filed with the Commission May 7, 2021)](https://www.sec.gov/Archives/edgar/data/1096343/000109634321000079/mkl05072021ex42.htm)</u> |
| <u>[4.1(k)](https://www.sec.gov/Archives/edgar/data/1096343/000109634324000066/mkl-2024notesx17thsuppleme.htm)</u> | <u>[Seventeenth Supplemental Indenture, dated as of May 16, 2024, between Markel Group Inc. and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (incorporated by reference from Exhibit 4.2 in the Registrant's report on Form 8-K filed with the Commission May 16, 2024)](https://www.sec.gov/Archives/edgar/data/1096343/000109634324000066/mkl-2024notesx17thsuppleme.htm)</u> |
| The registrant hereby agrees to furnish to the Securities and Exchange Commission, upon request, a copy of all other instruments defining the rights of holders of long-term debt of the registrant and its subsidiaries. | The registrant hereby agrees to furnish to the Securities and Exchange Commission, upon request, a copy of all other instruments defining the rights of holders of long-term debt of the registrant and its subsidiaries. |
| <u>[31.1](mkl03312026ex311.htm)</u> | <u>[Certification of Principal Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a)\*](mkl03312026ex311.htm)</u> |
| <u>[31.2](mkl03312026ex312.htm)</u> | <u>[Certification of Principal Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a)\*](mkl03312026ex312.htm)</u> |
| <u>[32.1](mkl03312026ex321.htm)</u> | <u>[Certification furnished Pursuant to 18 U.S.C. Section 1350\*](mkl03312026ex321.htm)</u> |
| 101 | The following consolidated financial statements from Markel Group Inc.'s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed on April 28, 2026, formatted in Inline XBRL: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Income (Loss) and Comprehensive Income (Loss), (iii) Consolidated Statements of Changes in Equity, (iv) Condensed Consolidated Statements of Cash Flows, and (v) Notes to Consolidated Financial Statements.\* |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

\* Filed with this report

------

<u>[**Table of Contents**](#i0d3a8af7c48740ac94a3c2b8c9b465ff_7)</u>

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, this 28<sup>th</sup> day of April 2026.

---

| | |
|:---|:---|
| Markel Group Inc. | Markel Group Inc. |
| By: | /s/ Thomas S. Gayner |
|  | Thomas S. Gayner |
|  | Chief Executive Officer |
|  | (Principal Executive Officer) |
| By: | /s/ Brian J. Costanzo |
|  | Brian J. Costanzo |
|  | Chief Financial Officer |
|  | (Principal Financial Officer) |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER** 

**PURSUANT TO RULE 13a-14(a)/15d-14(a)** 

I, Thomas S. Gayner, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Markel Group Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| April 28, 2026 | /s/ Thomas S. Gayner |
| | Thomas S. Gayner |
| | Chief Executive Officer |
| | (Principal Executive Officer) |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER** 

**PURSUANT TO RULE 13a-14(a)/15d-14(a)** 

I, Brian J. Costanzo, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Markel Group Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| April 28, 2026 | /s/ Brian J. Costanzo |
| | Brian J. Costanzo |
| | Chief Financial Officer |
| | (Principal Financial Officer) |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION** 

**FURNISHED PURSUANT TO 18 U.S.C. SECTION 1350**

In connection with the Quarterly Report of Markel Group Inc. (the "Company") on Form 10-Q for the period ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| April 28, 2026 | /s/ Thomas S. Gayner |
| | Thomas S. Gayner |
| | Chief Executive Officer |
| | (Principal Executive Officer) |
| | /s/ Brian J. Costanzo |
| | Brian J. Costanzo |
| | Chief Financial Officer |
| | (Principal Financial Officer) |

---

<br>